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Sodium deoxycholate (NaDC) is a small bile salt that was used in this 
dissertation to produce gelation of tris(hydroxymethyl)amino-methane (TRIS) solutions 
above, below, and near the pKa of NaDC. These solutions respectively yielded a neutral 
gelator, a charged gelator, and a mixture of each. Impacts of ionic interactions on gel 
formation were studied in detail and showed that pH can be used to modify many 
hydrogel properties including sol-gel temperature, crystallinity, and mechanical strength. 
It was also observed that pH modification of the hydrogels affected nanoparticle 
formation. Nanoparticles derived from a Group of Uniform Materials Based on Organic 
Salts (nanoGUMBOS), specifically cyanine-based NIR dyes, were templated within the 
hydrogel network for potential applications in tissue imaging. These nanoGUMBOS 
were found to be size-tunable, although material dependent. 
Several hydrogel formulations yielded a unique rheological finding of two stable 
regions of elastic modulus. Release of different solutes was investigated under different 
hydrogel conditions and at variable shear rate. Temperature, solute size, hydrogel 
formulation, and shear rate were all found to impact solute release. This suggests that 
NaDC/TRIS hydrogels can be used as injectable, topical, or patch-type drug delivery 
vehicles or as solute delivery vehicles in applications such as fertilizers and packaging.  
Enantiopreferential drug release from these hydrogels was also examined. 
Native gels exhibited significant release preference. This is of great importance to 
pharmaceutical applications due to the prevalence of racemic drugs. It was found that 
with facile modification, the enantiopreferential release could be inverted. Further 
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understanding of NaDC/TRIS gelation has broadened the tunability and 
multidimensional applications of these tailored hydrogel systems. 
A three-component GUMBOS derived from fluorescein, rhodamine B, and 
tetradecyltrihexyl phosphonium was synthesized and characterized. Nanoparticles 
prepared from this GUMBOS exhibited dual-wavelength fluorescence. Ratiometric 
analysis of these two emission bands revealed changes with pH, specifically between 
the biologically relevant values of pH 5 and pH 7. Thus, fluorescence microscopy was 
employed to image cancerous and normal breast cells incubated with nanoGUMBOS. 
Higher uptake of nanoGUMBOS and more pervasive fluorescence intensity were found 
in comparison to normal cells, showing great potential for fast, visual determination of 






1.1.  Classifications and properties of hydrogels 
“The colloidal condition, the ‘gel,’ is one which is easier to recognize than define.” 
This immortal quote of Jordan Lloyd in 1926 is a statement that still holds true today.1 
Hydrogels are prevalent in many areas of science and our everyday lives. For example, 
they are used as sensors,2,3 in soft electronics,4,5 and in drug delivery6,7 in addition to 
use in shampoo, diapers, and contact lenses. For this reason, many tests and 
definitions have been developed for gel determination; yet all are incomplete or not fully 
inclusive.1,8 One qualitative determination is the bubble rise test, in which a possible gel 
is bubbled with air. If the bubbles move through the sample on the timescale of the 
experiment, the sample is not a gel.9 On the other hand, more quantitative tests, such 
as the modulus comparison test, rely on rheology.8 A common definition of a hydrogel (a 
gel composed primarily of water or an aqueous solution) is a three-dimensional polymer 
network capable of retaining large amounts water.10 This definition is, however, 
incomplete. An important distinction must be made between polymeric hydrogels and 
molecular hydrogels. The primary difference is the type of gelator, the molecule 
immobilizing the water, as named. While there are many common characteristics 
between these two classes, there are also many impactful differences. 
Hydrogels of both classes tend to be viscoelastic, solid-like at low stress, and 
primarily composed of water.11 It should be noted that there is a vast array of gelators 
with an equivalent variety of properties. Polymeric gels can be composed of a covalently 
crosslinked network of synthetic or biological polymers and generally have relatively 
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high mechanical strength. Molecular gels are often formed by noncovalent interactions 
such as hydrogen bonding, π-π stacking, and hydrophobic interactions. However, some 
molecular gels are covalently bound.12 The gelator of a molecular gel is often a low 
molecular weight (LMW) molecule such as certain porphyrins13 or bile acids. Therefore, 
these molecular gels are often referred to as LMW or physical hydrogels. Benefits of 
such gels include biocompatibility, simple and inexpensive synthesis, 
thermoreversibility, and stimuli response.15 Each of these benefits is largely due to the 
lack of chemical crosslinking.16 Polymeric hydrogels have vast applicability and benefits 
(such as high mechanical strength), and will be discussed briefly in this work. However, 
the focus of this dissertation will be on LMW hydrogels. 
1.2.  Development and types of molecular hydrogels  
Of the currently known LMW hydrogelators, almost all have been discovered in 
the past 20 years.12,17 Early examples were primarily found through serendipity. It is 
only in recent years that they have been strategically designed. Design of LMW 
hydrogelators began by formulating molecules with structural similarities to those found 
serendipitously.12 For example, amphiphilic moieties and hydrogen bonding sites are 
prevalent in gelator design. The ability to rationally design a gelator has increased the 
application of hydrogels, because properties can be chosen to fit specific requirements.  
 The earliest known discovery of an LMW hydrogelator, uric acid, was 
documented in an 1841 paper by Lipowitz.18 In 1892, Brenzinger found that dibenzoyl 
cysteine could be used as an LMW hydrogelator.19 It has been suggested that such 
systems were not of interest until recent years due to the lack of terminology to describe 
and technology to understand the hydrogels.20,21 Several classes of molecules, 
3 
 
including amino acids,22,23 carbohydrates,24,25 and surfactants,26,27 were found to contain 
hydrogelators. With an increasing number of LMW hydrogelators discovered and the 
use of microscopy for visualization of gel structure, the 1900s saw a drastic increase in 
attention towards LMW hydrogels.8 As a result, the natural desire to design LMW 
hydrogelators increased as well. 
Rational design of small molecule hydrogelators began by mimicking and 
modifying organogelators (molecules known to gelate organic solvents) and 
hydrogelators that had previously been found serendipitously.12,17 Common to most 
hydrogelators are hydrophobic domains, such as the tails of many surfactants, and 
hydrogen bonding sites, as in the hydroxyl groups of carbohydrates.12 It can be 
expected then that any small molecule designed to be a hydrogelator might have one or 
both of these properties. In 1999 and 2000, the Hamilton group, for example, converted 
an organogelator to a series of hydrogelators by carboxylating and alkylating bis-urea.28 
A few years later, the Hanabusa group similarly converted a group of L-lysine based 
bis-amide organogelators to hydrogelators with the introduction of an ionic moiety, e.g. 
a cationic nitroaromatic group.29 Once a hydrogelator was discovered, similar molecules 
were often broadly screened for other hydrogelators. For example, a collection of 
naphthalene-dipeptide hydrogelators was developed by the Adams group in 2010 by 
varying three different substituent groups.30 As the library of LMW hydrogelators 
increases, so does the number of potential applications and consequently the number of 
hydrogelators designed for such specific functions. 
Applications of hydrogels can be listed endlessly. This vast array includes drug 
delivery,31,32 food (including processing and end-product),33,34 cosmetics,35 tissue 
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scaffolding,36,37 material templating,38,39 sensing,40-42 soft electronics,43,4 and optical 
devices.44,45 It is important to realize that each application, even within the same 
category of use, requires a discrete set of properties of the chosen hydrogel. For 
instance, in tissue scaffolding applications the mechanical strength required of a gel can 
vary greatly depending on the type of tissue being mimicked.46 It is for this reason that 
tunability is a strong benefit. Tunability can come from either modifications to the gelator 
as discussed, e.g. carboxylation or other functionalization, or from the addition of a 
modifier to the hydrogel formulation. Either mode of tunability, or indeed a combination 
of both, can provide the necessary characteristics for numerous applications.  
While rational design of LMW hydrogelators began as an exploratory function, 
focus has now shifted to the intentional development of molecules with desired 
properties for use in a particular application. This approach has recently been aimed 
toward the development of stimuli-responsive hydrogels.  
1.3.  Stimuli-responsive hydrogels 
Stimuli-responsive hydrogels are gels that change characteristics, or “respond,” 
when introduced to a stimulus. Common stimuli of interest include pH, light, and ion 
concentration.47 Sol-gel transitions are the most commonly exploited change in stimuli-
responsive hydrogels.14 However, volume changes,48 optical properties,49 swelling 
kinetics,50 and conductivity51 can also be affected by stimuli. These responsive 
hydrogels have gained recent interest because a change in physical or chemical 
properties in response to specified stimuli can be useful in many applications. For 




LMW, physical hydrogels are particularly suited for development into stimuli-
responsive materials based on three characteristics as described by Jan van Esch and 
colleagues12 First, the absence of covalent bonds between gelator molecules facilitates 
reversible gelation. This can be exploited in response to various triggers. Second, if it is 
well understood which moieties of the molecule participate in gelation, the gelator can 
be modified to have varied and tunable properties. For example, alkyl chains are often 
added for enhanced aggregation in aqueous media. Changes in chain length may be 
used to change physical properties. Finally, gelator molecules self-assemble into highly 
ordered patterns. These characteristics allow for the design of LMW hydrogels as 
stimuli-responsive materials. 
Sol-gel transitions that depend on pH are important in biological applications due 
to the specific pH of different parts of the body and caused by different conditions, such 
as the relative acidity of bacterial infections and cancer sites.47 Polypeptides have been 
explored for these purposes by several groups.52-54 The sequence of amino acids can 
be chosen such that sol-gel transitions take place at a wide range of pH values. A group 
of LMW hydrogelators based on N-(fluorenyl-9-methoxycarbonyl)-D-alanine-D-alanine 
have been shown to have a completely reversible sol-gel transition with change in pH.55 
In addition to full sol-gel transitions, some hydrogel materials have been developed to 
have pH-dependent shrinking and swelling.52,56,57 This can be exceptionally useful for 
continued release in response to desired pH, rather than a single use system. A 
common theme in the design of pH-responsive systems for drug delivery applications is 
the use of pH-dependent moieties such as amines and carboxylic acids.6 In every case, 
the ability to tune the transition pH for a desired application is ideal. 
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 Response to temperature is another useful characteristic in hydrogels for drug 
delivery.58 Among other uses, the most common is to employ a temperature induced 
gel-to-sol transition to release drugs within the body or a sol-to-gel transition for 
facilitated processing with the desired properties of a gel in vivo. Thus far, most work 
towards temperature-responsive hydrogels has been with polymeric gelators. Poly(N-
isopropylacrylamide) seems to be the most popular material base for this type of 
application.59,60 Other common thermoresponsive gelators include similar structures 
such as poly(N,N-diethylacrylamide)61,62 and copolymers including one or both of 
these.6 In addition to phase transitions, thermally triggered volume changes (i.e. 
swelling and shrinking) can also be useful in drug delivery. An interpenetrating network 
of poly(acrylic acid) and polyacrylamide, for example, swells in response to increased 
temperature, thereby changing the drug release rate.63,64 It is ideal if modifications (such 
as changes in component ratio) can be made to the hydrogel system to modify these 
responses to best fit individual applications. As more is understood about LMW 
hydrogels, work with temperature response will follow. 
 While pH and temperature are common triggers for stimuli-responsive hydrogels, 
response to other stimuli is gaining interest as well. Response to biomolecules is rapidly 
gaining attention due to its specificity, especially systems for insulin release triggered by 
glucose concentration.6 Hydrogels can also be designed to be responsive to light,65,66 
mechanical stress,67 electrical field,68,69 and salt composition or concentration.70,71 The 
utility of hydrogels is demonstrated by the multitude of hydrogel phase transition and 
volume change triggers studied and a correspondingly high number of hydrogel 
materials. It also further illustrates that the vast array of hydrogel applications requires 
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an equal array of hydrogel systems to choose from; ergo, the design of new, specifically 
tunable, hydrogels is of the utmost importance. 
1.4.  Hydrogels in drug delivery 
Hydrogels have long been investigated as drug delivery vehicles for two primary 
reasons. First, their inherent similarities to biological membranes make them suitable for 
such applications. Second, the wide range of hydrogel systems allows for diverse use 
across many types of delivery. For these two reasons, hydrogels have been applied in 
delivery systems ranging from wound dressings and topical applications to ocular and 
gastrointestinal deliveries.32 
The general similarity of hydrogels to biological membranes is a many-faceted 
resemblance that can be made even stronger with intentional modifications. Arguably 
the most important similarities are those of high water content and high porosity.72 The 
combination of these two properties facilitates diffusion of oxygen, nutrients, and drugs 
into sites of interest and diffusion of waste, heat, and dead cells out of the site.31 
Furthermore, specific gelators can be chosen or designed for increased biocompatibility 
and biodegradability. The development of stimuli-responsive hydrogels can be exploited 
to further enhance drug delivery. The benefits and diversity of hydrogel systems allow 
their broad application in several different types of drug delivery systems.  
1.4.1. Modes of drug delivery  
The requirements of drug delivery applications are at least as diverse and ever-
changing as the large number of systems currently available, if not more so. Therefore, 
it is of great importance that new drug delivery vehicles are continually being designed 
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and explored. Different modes of delivery, such as gastrointestinal and ocular delivery, 
as well as their corresponding requirements of a delivery system will be discussed 
briefly as an example of the extent of this diversity. 
 Gastrointestinal environments are common targets of oral drug delivery.73 Robust 
hydrogels are required for this type of application, because they need to protect drugs 
from harsh digestive processes until the desired site of application is reached. In 
addition to being robust, orally administered drug delivery vehicles also need to be 
nontoxic.32 Polymeric gelators such as pectin,74 cellulose acetate,75 and other 
biopolymers are often chosen for this reason. Because each section of the digestive 
tract has a distinct pH,76 hydrogels responsive to pH are particularly useful for 
gastrointestinal delivery.51 For example, a system can be designed such that it 
degrades or swells at the pH value of the desired application site to release a drug. 
LMW gelators such as chitosan and alginate gels have both been used in such 
cases.77,78 
 Ocular delivery is a particularly challenging type of delivery due to the efficient 
disposal processes and protective barriers of the eye. Topical applications to the eye 
are often washed away or diluted due to the 75% loss of ophthalmic solution.79 
Membranes such as the conjunctiva and three layers of the cornea inhibit passage of 
foreign substances into the eyes and each has different requirements (e.g. polarity) for 
transportation to occur.80 Injectable devices are one way to overcome these obstacles. 
P(NIPAAm-co-Dex-Lactate HEMA) hydrogels, for example, were developed for 
significant release when injected into the subconjuctival space of the eyes. Such 
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administration circumvents the eye’s barriers, and the high release allows for sufficient 
dosing after dilution processes.81  
 Transdermal delivery of substances to the body can be speculated to date back 
to the body painting of our prehistoric ancestors.82 Modern use of transdermal delivery 
began with a motion sickness patch in 1979 and has grown to include smoking 
cessation aids, hormone therapy, birth control, and many other uses. It was estimated in 
2008 that over one billion transdermal patches were produced per year.83 Transdermal 
delivery overcomes the discomfort and expense of injectable drug delivery vehicles. 
This type of delivery can also be used to avoid premature metabolism and harmful side 
effects that may be encountered with oral drug delivery vehicles. As with ocular delivery, 
the difficulty with transdermal application is the natural barriers that have evolved to 
keep exogenous substances out.84 Hydrogels have been useful in the design of 
transdermal patches due to the broad flexibility of their design,85 their ability to contour 
to the application site, and their ability to be coupled with iontophoresis (a method of 
applying an electric field to induce transport across the membrane).86 Poloxamer 407 
gels were found to release peptide drugs such as insulin transdermally, enhanced by 
coupling with iontophoresis. This study exhibits an additional benefit of using a gel 
system in that chemical enhancers can be loaded within a gel system to further facilitate 
drug transport through the skin.  
 Subcutaneous delivery has become a popular approach used to completely 
bypass the skins natural barriers. Lee et al. designed triblock PEG copolymers for 
subcutaneous antibody delivery.87 For subcutaneous delivery, it is desirable that 
hydrogels be injectable at ambient conditions for facile administration. In many cases, 
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however, hydrogel materials are not injectable at ambient conditions, making 
thermoresponsive properties desirable for subcutaneous applications. For that reason, it 
is desirable to design hydrogels with sol-to-gel transition at body temperature for 
subcutaneous injection, such as the chitosan/polyelectrolyte gels designed by 
Matanovic et al. for heparin release.88  
1.4.2. LMW benefits of hydrogels for drug delivery 
As has been previously mentioned, LMW hydrogels can provide significant 
enhancements in drug delivery applications. In many ways the synthesis of LMW 
hydrogels, specifically, is superior to that of polymeric hydrogels when used for drug 
delivery applications. For example, LMW hydrogels typically do not require harsh 
initiation triggers because they are self-assembled.89,90 A common problem with 
polymeric systems is the high probability of the presence of unreacted monomer, 
typically a toxic molecule.91,92 The small molecules used to gelate aqueous solutions are 
typically nontoxic, thereby eliminating this complication. Synthesis of LMW hydrogels 
are often less expensive than comparable polymeric systems due simply to the 
reduction of steps. Initiation, subsequent polymerization, and removal of unreacted 
monomer and crosslinker are typically not required steps in the synthesis of LMW 
hydrogels. Simple and inexpensive synthesis means that such materials can be used in 
a multitude of more common applications in addition to vital or sophisticated 
applications.  
The absence of a chemical crosslinker in and of itself provides a multifaceted 
advantage. Firstly, crosslinkers tend to be toxic, so any unreacted excess will be a 
deficiency.72 Most importantly, however, are the properties resulting from the absence of 
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chemical crosslinking, namely thixotropy and thermoreversibilty.93 Agitation and 
temperature can each temporarily disturb the physical interactions immobilizing an LMW 
hydrogel. However, the reestablishment of hydrogen bonding, π-π stacking, 
hydrophobic interactions, etc. will occur over time, thereby gelating again. Because this 
“physical crosslinking” is more easily perturbed than a chemical crosslink, 
biodegradation and excretion from the body are typically superior in LMW hydrogels.17 
As with all hydrogel applications, it is important to note that different properties 
are beneficial for different types of drug delivery applications. Drug delivery can be 
categorized by the route of delivery. Wound dressing, subcutaneous, ocular, oral, and 
surgical implantations are a few representative types of delivery, each with specific 
needs from a delivery system. Hydrogels used as wound dressings for example, should 
have maximum porosity for removal of waste and transfer or oxygen, drugs, and 
nutrients.94,95,96 They should also be deformable, as opposed to a rigid gel, in order to 
increase contact area (thereby facilitating molecular and heat diffusion further), and to 
provide a physical barrier to microbes and physical damage.97,98 Ocular delivery, on the 
other hand, requires a hydrogel that can withstand the rapid degradation processes of 
the eyes. This can be attained through use of a more rigid contact lens.99  
LMW hydrogels exhibit properties that make them beneficial for many types of 
drug delivery.31,32,100 Facile, inexpensive synthesis makes them widely applicable, while 
the absence of chemical crosslinking provides additional benefits. Thermoreversibility, 
thixotropy, simple biodegradation, and biocompatibility all enhance LMW hydrogels 
toward drug delivery applications. The wide variety of available LMW gelators also 
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allows for selection of properties suited for a specific desired application. Bile salts are 
one example of LMW gelator and will be explored further in this dissertation.  
1.5. Bile salt gels 
Bile salts are a class of molecules found in the liver of most vertebrates. Their 
ability to form micelles contributes to digestion, dietary fat absorption, cholesterol 
elimination, and other metabolic processes.101 This type of salt comprises a large family 
of molecules, but all are derived from cholesterol and consequently share some of its 
characteristics. Cholesterol and all bile acids have a steroid backbone. This includes 
three six-membered rings and one five-membered ring (see Figure 1.1) and a five- or 
eight- carbon side chain often ending in a carboxyl group. Variation between different 
members of this class can be due to varied hydroxylation and leads to different 
properties and, consequently, functions. 
 
Figure 1.1. Structure of cholesterol. 
Bile salt media is used to distinguish pneumococcus (the pneumonia-causing 
bacteria) from other cocci (spherically-shaped bacteria) based on dissolution.102,103 The 
serendipitous discovery of bile salt hydrogelation was first documented through this use. 
Harry Sobotka and Nina Czeczowiczka were consulted about this discovery and, in 
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1958, published the first study investigating bile salt hydrogels.104 The gelation of 
deoxycholic, cholic, glycocholic, and lithocholic acid was explored. They found that 
deoxycholic and lithocholic acid each formed gels while the others did not. A cholic acid 
trimer (tripodal cholamide), however, was found by Uday Maitra and colleagues to 
gelate water and aqueous solutions.105 As is found throughout the literature, this is an 
indication of the sensitivity of LMW physical hydrogels. For gelation to occur there must 
be a delicate balance between the hydrophobic and hydrophilic moieties and between 
the physical interactions immobilizing the network.17 Moreover, even molecules that do 
exhibit the needed balance require certain conditions for gelation. With bile acids for 
instance, a relatively low pH is often needed to increase the aggregation number 
sufficiently for gelation. 
Gelation by these molecules can be attributed to several of their 
characteristics.11,106 Bile acids have a relatively hydrophilic convex face due to the 
presence of hydroxyl groups. They also have a relatively hydrophobic concave face due 
to the presence of aliphatic groups. This results in a facial amphiphilicity that imparts 
hydrophobic interactions and, consequently, aggregation. Additionally, hydroxyl groups 
can participate in hydrogen bonding, further ordering a bile salt solution.  
Despite the fact that bile salt gels have been around for several decades, 
significant work is still being done on their development. This widespread interest is due 
in part to the fact that bile salts are highly derivitizable.14 This means that systems can 
be facilely designed and tuned for specific applications. Applications of bile acid gels are 
widespread and include everything from sensing materials to nanoelectronics to drug 
delivery systems.  
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From about 1958-1960, Blow and Rich did pioneering work on the understanding 
of the gelation mechanism of bile salts, specifically sodium deoxycholate.107,108 It was 
found that gelation of deoxycholate solutions is related to the surfactant properties of 
the molecule and the resultant micelle formation. Unlike typical micelles, deoxycholate 
molecules form “huge,” helical micelles with regular intervals. The large helices 
(determined to be 36 Å) are relatively rigid and, most importantly, have a large degree 
of molecular specificity in relation to typical micellar systems. That is to say, small 
changes to the deoxycholate structure can result in a complete destruction of the 
complexing process. Another important distinction between a typical micelle and 
deoxycholate hydrogels is the observation of crystalline spacing. While soap solutions 
are determined to be “liquid,”109 deoxycholate gels exhibit a definite crystalline spacing 
when analyzed by X-ray diffraction. These findings were critical for the further 
understanding, development, and application of deoxycholate hydrogels.  
 Uday Maitra is a leader in the field of bile acid gels. His group has done work with 
several different bile acid gelators under many sets of conditions. 105,106,110,111,112 Goals 
of this group include development of a broad array of systems for various applications in 
addition to further understanding the properties of the gel, including structure and 
dynamics. The Maitra group employed a battery of techniques in order to characterize 
these materials. This includes spectroscopy techniques (e.g. steady-state and time-
resolved fluorescence, dynamic light scattering), mechanical techniques (e.g. rheology, 
viscometry), and other techniques such as electron microscopy and neutron scattering.  
 Bile acid gels have a long history of development that still continues in current 
research, as evidenced by the continual publication of research articles, books, and 
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review papers. Gelators have been designed and discovered with neutral, cationic, and 
anionic side chains.72,113,114 Gelation has been found to be influenced by many factors. 
One such factor is the pH value of the aqueous solution to be immobilized.115 In almost 
all cases, a more acidic solution enhanced strength and speed of gelation. Salt 
concentration was also found to influence many systems. However, this is a more 
complicated factor. In some cases, salt enhances gelation116 while in others, it disrupts 
or inhibits it.117 As previously mentioned, the most important thing to note about such 
varied systems is that each profile of properties can be suited toward specific 
applications. 
 The applications of bile acid gels are as many and varied as the number of 
systems available. Common applications can be categorized into groups including use 
as rigid platforms, molecular recognition devices, separation membranes, synthesis 
templates, use in optoelectronics, and biological applications. Some examples will be 
described herein; however, there are many review articles that discuss these 
applications in detail. 118-122 
 Rigid platforms, such as a hydrogel, can be used to direct molecular orientation 
and immobilize molecules within a network. The Shinkai group, for example, utilizes this 
immobilization for use as a fluorescence-based pH sensor.123 A fluorescent moiety, 
1,10-phenanthroline, was incorporated into a cholesterol-based gel. Both fluorescence 
intensity and emission wavelength were found to change with proton concentration in 
this study. Due to the immobilization properties of the hydrogel network, the rigid 
platform can also be used for the promotion of electronic energy transfer.110 
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An emerging use of bile acid hydrogels is for the templating of nanomaterials 
synthesized within the hydrogel network. Bhattacharya, a leader in the field of bile acid 
gels, used stearic acid-based hydrogels for controlled templating of silver 
nanoparticles.124 Bile acid hydrogels are well suited for nanotemplating because of their 
well-defined and easily tunable properties. Bhat and Maitra have also used thiolated 
cholic acid-based hydrogels to template and stabilize gold nanoparticles.111 This is an 
important application of hydrogel materials due to the many uses of metal 
nanoparticles.  
Bile acid hydrogels are particularly well-suited for biological applications due to 
their high water content, porosity, and biocompatibility. Drug delivery will be discussed 
in detail in the following sections. Other biological applications include use as artificial 
tissues125 and cell immobilization. Cell immobilization not only utilizes, but requires, the 
high porosity and rigid mesh network of a hydrogel. Cells are large enough that they 
are “macroencapsulated” within the gel network.126-128 The porosity allows for diffusion 
of nutrients and oxygen into the cells and waste and heat out of the cells.46 
Regardless of the category of application, stimuli-responsive bile gels can be 
used for enhancement. As discussed with other stimuli-responsive materials, bile gels 
have been designed to respond to external stimuli such as light,129 temperature130,112 
and pH with changes in phase, color, or volume. The Kolehmainen group, for example, 
has designed a stigmasterol-based hydrogelator that has a sol-gel transition triggered 
by acidification.131 Conversely, Liu et al. designed a cholesteryl glycinate-based 
hydrogelator that has a sol-gel transition with the addition of a base.132 The multitude of 
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bile acid gelators and their endless tunability provide potential for design of many 
stimuli-responsive bile gel materials. 
1.5.1. Bile salt gels in drug delivery  
Thus far, bile gel drug delivery has not been exhaustively explored, although 
some important work has been published indicating great potential. The Bernkop-
Schnürch group was the first to evaluate sodium deoxycholate hydrogels for their use 
as drug delivery vehicles.133 Release of the model drug rutin was examined and 
determined to be affected by sugars such as mannitol. Deoxycholate hydrogels were 
found to enhance permeation in this case. This property can be extremely beneficial for 
increasing drug uptake. Due to the many potential benefits of bile salt hydrogels and the 
lack of research using them, there is a significant opportunity for exploration in this field. 
1.5.2. Benefits of NaDC/TRIS hydrogels 
The primary focus of this dissertation is the development and exploration of 
sodium deoxycholate (NaDC)/tris(hydroxymethyl)aminomethane (TRIS) hydrogels. 
These hydrogels are LMW and physically crosslinked, meaning that they have all the 
advantages associated with such systems as previously described. In addition to 
thixotropy, thermoreversibility, biocompatibility, etc., they also exhibit a host of other 
benefits that make them suitable for drug delivery and other applications. These 
beneficial properties will be discussed and demonstrated at length in the following 
chapters. In summary, NaDC/TRIS hydrogels are highly tunable with facile 
modifications, injectable at room temperature, optically transparent, and can be loaded 
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with drugs or other materials concurrent with gelation. Therefore, NaDC/TRIS hydrogels 
are exceptional candidates for a multitude of applications. 
1.6. Group of Uniform Materials Based on Organic Salts for biomedical 
applications 
Hydrogels are only one example of interesting materials for biomedical 
applications. A Group of Uniform Materials Based on Organic Salts (GUMBOS) also 
show great promise and utility in the field of biomedicine. The term GUMBOS refers to 
organic salt materials with a melting point range of 25 to 250 °C renowned for tunability 
and broad applicability.134-138 In some respects, GUMBOS may be thought of as solid 
phase ionic liquids since the same counterions are often used in both. Primary 
differences lie in the melting point range of these organic salts.  While applications of 
ionic liquids are extensive due to longer existence, GUMBOS have more recently 
proven useful in applications as varied as solar cell sensitization139 and molar mass 
sensing of volatile organic compounds by use of quartz crystal microbalance.140 This 
dissertation will involve discussion and application of GUMBOS for biomedical 
applications. Thus far, GUMBOS have been used in at least three notable ways toward 
this field. Li et al. exploited the facile tunability of GUMBOS to incorporate luminescent 
and paramagnetic properties into several GUMBOS found to selectively target cancer 
cells in vitro.141 The inhibition of growth in tumor cells was attributed to a cation choice 
of aryltriphenylphosphonium. Tunability of GUMBOS has also been exploited by Magut 
et al., demonstrating an improvement in selective cytotoxicity toward cancer cells with a 
simple change in anion.142 Das et al. have investigated the intersection of two exciting 
materials, GUMBOS and LMW hydrogels.143 In that study, LMW hydrogels were shown 
to provide a tunable template for nanoGUMBOS synthesis. Nanoparticle size and 
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spectral properties were found to be tunable in ways pertinent for a variety of biomedical 
applications. For example, fluorescence emission wavelength was tuned with slight 
modification to the hydrogels. These exceptional materials, GUMBOS and hydrogels, 
show great potential for biomedical applications ranging from imaging to drug delivery 
vehicles to active drugs. Both will be explored further in this dissertation. 
1.7. Instrumentation 
1.7.1. Ultraviolet-visible spectroscopy 
Ultraviolet-visible (UV-vis) spectroscopy is an analytical technique used for 
qualification and quantification of molecules that absorb light in the UV-vis range of the 
electromagnetic spectrum, from about 200-800 nm. UV-vis spectrophotometers are 
typically comprised of a light source, monochromator, sample holder, and detector 
(Figure 1.2). Light from the source is passed through a monochromator so that 
absorption can be measured at distinct wavelengths. The filtered light reaches the 
sample, and a portion of the light is transmitted through the sample and measured by 
the detector, typically a photomultiplier tube or a photodiode. Transmission (T) is the 
ratio of incident light (I0) to transmitted light (I), and absorbance (A) is calculated as the 
negative natural log of transmission. 
    
Beer-Lambert’s law can be used to calculate sample concentration from absorbance 
using the equation A=εbc, where ε is the molar absorptivity coefficient characteristic of a 
molecule, b is the pathlength of the light through the sample, and c is the concentration 





Figure 1.2. Schematic representation of a UV-vis absorbance instrument.  
1.7.2. Fluorescence spectroscopy 
Fluorescence is a phenomenon associated with radiative transitions of a 
molecule between energy states of the same multiplicity, for example from the excited 
S1 singlet state to the ground S0 singlet state. Fluorescence spectroscopy is a technique 
used to measure and analyze the radiative light emitted during this phenomenon. For 
aromatic hydrocarbons, fluorescence occurs on a timescale of 10-9 seconds. A 
proportionality constant called quantum yield (φf) can be used to describe the ratio of 
photons that fluoresce to the number that was absorbed: 
#	 	 	 	
#	 	 	 	 	
 
Fluorescence and related processes are commonly illustrated in a Jablonski diagram 
(Figure 1.3). Absorbance (A) and fluorescence (F) are depicted along with the 
competing processes of internal conversion (IC), intersystem crossing (ISC), and 
phosphorescence (P). IC is a nonradiative decay between two coupled vibrational 
states of different energy levels. ISC is also a nonradiative transition occurring between 
two states of different multiplicities, promoting phosphorescence. Phosphorescence 
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occurs after ISC to a different multiplicity (e.g. singlet to triplet). It typically occurs on a 
much slower time scale than fluorescence because it is a kinetically unfavored 
transition. 
 
Figure 1.3. Jablonski diagram depicting absorbance (A), fluorescence (F), and 
competing processes (IC, ISC, P).  
 Instrumentation for fluorescence spectroscopy is typically configured in a right 
angle geometry (Figure 1.4) Typical light sources include mercury or xenon arc lamps. 
Light passes through a monochromator before reaching the sample. Light emitted at 90° 
from the incident light is primarily passed through a second monochromator and 
collected. Photomultiplier tubes are often used for signal amplification before data is 
sent to the computer for processing.  
1.7.3. Differential scanning calorimetry 
Differential scanning calorimetry is a type of thermal analysis in which the 
difference in heat flow between a sample and a reference is measured as a function of 




Figure 1.4. Schematic diagram of a fluorescence spectrophotometer. 
heated concurrently in a sample chamber. Typically, heating is computer controlled and 
linear at a specified rate, for example 5 °C/minute. Thermocouple junctions are used to 
quantify the differential heat flow of the sample and reference. The resulting output from 
the computer is a thermogram (Figure 1.5), a plot of temperature versus differential heat 
flow.  
Applications of DSC often include investigation of transitions. For example, 
melting point onset and maximum melting temperature can be found through DSC. 
Similarly, DSC can be used to determine the glass transition temperature. For 
amorphous materials, this is the temperature at which the material reversibly transitions 
between a flexible state and a brittle state. Through integration of thermogram curves, 
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the enthalpies of transitions can be found as well. DSC can also be used to obtain 
information on crystallization such as degree of crystallization and changes in crystalline 
phase, such as with dissolution. Similarly, formation of liquid crystals or eutectic points 
can be determined as well. The many applications of DSC have been used in industries 
such as pharmaceuticals for determination of drug purity and food industries for 
processing and packaging temperatures. Any event, chemical or physical, that results in 
a change of heat flow (exo- or endo-thermic) can be considered for DSC evaluation. 
 
Figure 1.5. Depiction of a thermogram including typical transitions. Note that in a 
thermogram, endothermic transitions may be represented as “up” or “down” with 
exothermic transitions being the opposite. 
1.7.4. Polarized optical microscopy 
Polarized optical microscopy (POM), also called cross-polarized light microscopy, 
is a technique used for visualization of birefringence, typically giving information about 
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the crystallinity of a material. The apparatus is that of a typical optical microscope with 
the addition of a pre-sample polarizer and a post-sample polarizer, often called an 
analyzer. The unfiltered light source vibrates at all angles along an axis until it reaches 
the first polarizer, reducing the vibration to one plane. The second polarizer is set at 90° 
(hence “cross-polarized”), so that only light that has been split from the original plane is 
observed. Birefringence is an indication of crystallinity. Therefore, the images obtained 
reveal the organization and geometry of a material’s crystal packing. A sample that 
does not exhibit birefringence, such as an amorphous material, will result in a dark 
image. 
1.7.5. X-Ray diffraction 
X-Ray diffraction (XRD) is an analytical technique based on diffraction of x-rays 
in a crystalline sample. Bragg’s law describes a condition of scattering in which: 
2 sin . 
where n is an integer, λ is the incident wavelength, d is the distance between planes of 
the sample crystal, and θ is the beam angle. In order to fit this law, the interplanar 
distance must be approximately equal to the incident wavelength. Resulting diffraction 
patterns can give information on the phase of the sample material, the spatial 
arrangement of atoms within a crystal, and, with use of a database, the chemical 
makeup of a sample. Degree of crystallinity can also be determined using the intensity 
of scattering. The instrumentation is parallel to any spectroscopic method in that there is 
a source, a filter or monochromator, a sample holder, a detector, and a processor 
(Figure 1.6). X-rays are typically produced by a cathode ray tube. When the incident 
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beam reaches the sample, any crystallinity that obeys Bragg’s law will result in a 
diffracted beam. The pattern is typically processed as 2θ versus electron counts and 
can be used as a fingerprint for a particular substance. 
 
Figure 1.6. Schematic diagram of an x-ray diffractometer. An x-ray source bombards a 
sample, and the diffraction pattern is recorded.  
1.7.6. Transmission electron microscopy (TEM)  
Electron microscopy is a technique used to overcome the resolution limitations of 
typical optical microscopes by using an electron beam under vacuum instead of a light 
beam. Due to the enhanced magnification, electron microscopy has become a valuable 
tool for the visualization of nanoscale materials. An electron gun generates an electron 
beam that is focused on the sample using a series of lenses (Figure 1.7). Samples are 
thinly coated onto a grid often composed of carbon-coated copper. In transmission 
electron microscopy (TEM), the electrons transmitted by the sample are captured as an 
image by a phosphorescent screen and a charge-coupled device (CCD). Consequently, 
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areas of the sample that are denser result in a darker image, while areas that are less 
dense result in a brighter image.  
 
Figure 1.7. Schematic diagram of a transmission electron microscope. The yellow 
represents the path of the electron beam through sample and lenses. 
1.7.7. Rheology 
Rheology is the study of the flow properties of a material. In a typical experiment, 
stress is applied to a material while the resulting strain is measured. One type of 
instrumentation does this with a parallel plate geometry (Figure 1.8). This analytical 
technique can be used to gain understanding of complex structures such as colloids 
and suspensions. Behaviors such as thixotropy, shear thinning, or shear thickening can 
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be analyzed by rheology as well. Essentially, rheology is useful for viscoelastic 
materials, those that exhibit both fluid-like and solid-like responses to stress. 
Viscoelasticity is represented by the complex modulus, G*. The complex modulus is 
composed of two moduli, the viscous or loss modulus (denoted G”) and the elastic or 
storage modulus (denoted G’). The terms viscous and elastic refer to the solid- or liquid- 
like behavior of the material. The terms loss or storage refer to whether energy is stored 
in the material or released as heat. The scope of applications of this technique is 
extremely broad and varied. Within this dissertation, rheology is used to determine the 
mechanical strength of hydrogel materials as determined through examination of the 




Figure 1.8. Diagram of a plate geometry rheometer. The sample of interest (yellow) is 
pressed between a sample holder and an oscillating plate. 
1.8. Scope of the dissertation  
In this dissertation, I explore the use of two new materials in a variety of 
biomedical applications – NaDC/TRIS-based hydrogels and two different GUMBOS. 
Chapters 2 and 3 are an examination of the characteristics and delivery applications of 
a new class of materials, sodium deoxycholate/TRIS-based hydrogels. In Chapter 2, the 
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effects of modifications to the pH and concentration of the buffer solution on the 
properties of the resultant hydrogel were evaluated. A broad range of analyses including 
thermal and mechanical measurements was performed to better understand the 
characteristics of these materials. These materials were also evaluated for their use in 
templating organic nanoparticles derived from GUMBOS. Preliminary studies also 
probed the use of NaDC/TRIS hydrogels for use as injectable drug delivery vehicles. In 
the third chapter of this dissertation, several formulations of NaDC/TRIS hydrogels were 
evaluated as sustained release devices. The effect of shearing was tested to determine 
the utility of the materials as injectable or spreadable drug delivery devices compared to 
implanted or dressing applications. The effects of drug size, temperature, and loaded 
drug concentration were also examined. The use of NaDC/TRIS hydrogels for 
enantioselective drug release is also investigated in this chapter. In addition to 
preferential release of one enantiomer in the native state, modifications were also found 
to switch the preferential release to the other enantiomer. Chapter 4 is a description of 
the synthesis of a three component GUMBOS derived from fluorescein, rhodamine B, 
and tetradecyltrihexyl phosphonium. Nanoparticles of this material were explored as a 
ratiometric, FRET-based pH sensor with particular sensitivity between the biologically 
relevant pH values of 5 and 7. Fluorescence microscopy of these nanoGUMBOS varied 
greatly between cancer and normal cells, indicating incredible potential for use of these 
nanoGUMBOS in visual diagnosis of cancer 
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SODIUM DEOXYCHOLATE HYDROGELS: EFFECTS OF 




Bile acids such as sodium deoxycholate (NaDC) have long been known as 
hydrogelators.1,2 However, it is only during the past couple of decades that low 
molecular weight (LMW) gelators, such as some steroids, have been studied 
extensively.3 Steroids (including bile acids) are composed of a tetracyclic ring system 
with functional groups often including hydroxyl groups and an aliphatic side chain.4 The 
rigidity of the steroid backbone and the stereochemistry of hydroxyl functionalities result 
in facial amphiphilicity in NaDC, thereby enhancing formation of aqueous pools 
immobilized by a hydrophobic gel network.5 In pure water, the gelation mechanism of 
NaDC is considered to result from primarily entangled micellization,6 forming an overall 
helical structure.1 The addition of a modifier such as TRIS7 or mannitol8 has been 
shown to contribute hydrogen bonding to this gelation mechanism.  
In addition to NaDC, LMW gelators include chitosan,9 azo dyes,10 nucleoside 
derivatives,11 and many others.12 The myriad of LMW gelators allow a broad array of 
applications such as nanofabrication,13,14 biomedical engineering,15 separation 
science,16 and sensing.17 Development of a more diverse group of gels through 
mechanical and thermal experimentation is essential due to such broad applicability.18,19 
 
*This chapter previously appeared as “McNeel, K. E.; Das, S.; Siraj, N.; Negulescu, I. I.; 
Warner, I. M., Sodium Deoxycholate Hydrogels: Effects of Modifications on Gelation, 
Drug Release, and Nanotemplating”. Reproduced with permission from The Journal of 




It has been established that polymeric hydrogels are typically stronger in durability due 
to covalently cross-linked polymerization, making them more useful for actuators and 
other material applications.20 The physicochemical interactions of LMW hydrogels are 
much weaker in terms of durability; thus an increase in mechanical strength may be 
desirable, especially for bioengineering.  
 Gels with variable mechanical strengths are expected to provide variable 
templating capabilities for nanoparticle fabrication. The ability to develop a hydrogel with 
a designable template is of importance to nanoscience due to the many useful 
properties of nanoparticles dictated by particle size.21,22 These properties have been 
found to include surface control and interaction with cells and other physiological media 
making nanoparticles applicable in biosensors, drug delivery systems, and 
bioengineering.22,23 Nanoparticles derived from a Group of Uniform Materials Based on 
Organic Salts (GUMBOS), i.e. nanoGUMBOS, have previously been formed by use of a 
variety of methods.24,25,26 This class of materials, GUMBOS, are solid phase materials 
with tunable properties similar to ionic liquids. However, GUMBOS differ from ionic 
liquids in that they are primarily used in the solid state and have melting points between 
25 and 250 °C.21 An exponentially increasing number of applications27 including optical 
electronics,21-30 biological imaging,24 solar cell sensitizing,31 cancer targeting,21,32 
antibacterial,33 and molecular weight sensing functions34,35 make GUMBOS an 
interesting class of materials to study. Das et al. have recently studied NaDC/TRIS 
hydrogels as templates for size-tunable preparation of organic GUMBOS 
nanoparticles.7 In their method, hydrophobic nanoGUMBOS are formed similarly to a 
reverse micelle synthesis without a surfactant.7,36 The GUMBOS of greatest interest are 
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in a water miscible solution (e.g. ethanol). Thus, the solvated GUMBOS preferentially 
moves to hydrophilic pockets consequently forming nanoGUMBOS. Thus far, neither 
the composition of GUMBOS nor the pH of the hydrogel have been shown to affect the 
resultant size of nanoGUMBOS templated by these materials.  
In this study, I desire to further understand the modified gelation mechanism and 
expand the applicability of NaDC/TRIS hydrogels by investigating new materials under 
previously unknown conditions. Herein, I report the pH dependence of gelation at 
various TRIS concentrations through investigations of two distinctly different pH values: 
pH 5.5 well below the pKa of NaDC2, 37 and pH 7.4, the physiological pH, which is above 
the pKa of NaDC. An intermediate pH value of 6.8, i.e. near the pKa of NaDC, was also 
investigated. Each pH value was found to yield different properties in the resultant 
hydrogels indicating that ionic interactions are an important factor contributing to the 
gelation process. Through investigation of gelation, several properties were found to be 
tunable towards desired applications including sol-gel temperature, mechanical 
strength, templating capabilities, and viscoelasticity. NanoGUMBOS derived from three 
different NIR dyes were synthesized, and it was determined that hydrogel conditions 
and GUMBOS composition influenced particle size. Unique viscoelastic properties were 
found that prompted further investigations of small molecule release. Namely, two 
stable regions were found in the elastic modulus of several formulations, indicating 
great potential as injectable drug delivery vehicles. In order to demonstrate the utility of 




2.2. Experimental details 
2.2.1. Materials 
Sodium deoxycholate (NaDC), tris(hydroxymethyl)aminomethane (TRIS), 6-
propionyl-2-(dimethylamino)naphthalene (Prodan), 8-anilino-1-naphthalenesulfonic acid 
(ANS), 1,1′,3,3,3′,3′-hexamethylindotricarbocyanine (HMT) iodide (97%), 
bis(trifluoromethane)sulfonimide (NTf2) lithium salt, and bis(2-ethylhexyl) sulfosuccinate 
(AOT) sodium salt (≥ 99%), were purchased from Sigma Aldrich and used as received. 
Sodium tetraphenylborate (TPB) was purchased from TCI America and used as 
received. Ultrathin Carbon Type-A copper grids (CF400-Cu; Ted Pella, Inc.; Redding, 
CA) were used for TEM imaging. Triply deionized water (18 MΩ cm) was obtained from 
an Aries Filterworks high purity water system and used for all experiments. 
2.2.2. Selection of hydrogels 
TRIS buffer solutions were prepared at concentrations of 25, 50, 100, 200, 250, 
300, 400, and 500 mM. By use of concentrated and/or dilute hydrochloric acid, each 
concentration was adjusted from an initial pH value greater than 10 to each of four pH 
values: 5.5, 6.0, 6.8, and 7.4, generating a total of 32 individual samples. Solid NaDC 
was added to each solution to provide a concentration of 20 mM, followed immediately 
by 30 seconds of vortexing. Each sample was then bath sonicated for 20 minutes. The 
samples were allowed to stabilize at 5 °C overnight before analyses. Hydrophobicity 
studies using the fluorescent probe Prodan were employed for determining which of the 
32 samples would be pursued for further study (Table 2.1). 
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Table 2.1. Concentrations of TRIS buffer at each pH value selected for study. 
 
2.2.3. Characterization of hydrogels 
Hydrogels were characterized using several techniques. X-ray diffraction studies 
were performed on air-dried hydrogels using a Brüker/Siemens D5000 automated 
powder X-ray diffractometer, and diffraction patterns were analyzed using MDI Jade 
9.4.5 software. An Olympus BH polarizing optical microscope with an MD 1900 camera 
was used to obtain POM micrographs. The polarizer was set to 90°, and the analyzer 
was set to 0°. The hydrogels were drop-cast onto pre-cleaned glass slides and left to 
dry, with a thin layer remaining after solvent evaporation. A Thermal Analysis (TA) 
differential scanning calorimeter 2920 was used to determine sol-gel temperatures. 
Samples were heated in hermetic pans from 10 °C to 80 °C at a rate of 2 °C per minute. 
A TA AR 1000 rheometer (TA Instruments, Inc., Waters Corp., New Castle, DE) with 
stainless steel plate geometry was used to determine the rheological properties of the 
hydrogels, specifically the G’ and G” moduli. The fluorescent probe ANS was used to 
characterize the rigidity of hydrogel fibers and size of aqueous pools through 
fluorescence anisotropy (r) measurements. Fluorescence anisotropy is a measure of the 




pH 5.5 25, 100, 200, 250, 300, and 500
pH 6.0 25, 100, 200, 300, and 500
pH 6.8 50, 100, 200, and 400
pH 7.4 25, 100, 200, 300, and 500
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Anisotropy values can vary between -0.2 and 0.4, where -0.2 indicates free rotation and 
0.4 indicates completely restricted rotation. To acquire these measurements, the light 
source is polarized either vertically (v) or horizontally (h) before absorption, and the 
emission is polarized either parallel or perpendicular to the source polarization. In my 
studies, ANS was excited at 360 nm, and values of fluorescence anisotropy were 
calculated at 430 and 520 nm. 
2.2.4. Synthesis and characterization of [HMT][NTf2] and [HMT][TPB] GUMBOS 
The GUMBOS [HMT][NTf2], [HMT][TPB], and [HMT][AOT] were synthesized 
using a metathesis reaction, commonly referred to as an anion exchange method.24 
Characterizations of GUMBOS were performed using 1H (Bruker Avance 400, 
CDCl3) and 19F NMR (Bruker DPX 250, CDCl3). 
2.2.5. Synthesis of nanoGUMBOS in NaDC hydrogels 
After addition of 20 mM NaDC to each TRIS solution, a 1 mM ethanolic solution 
of [HMT][NTf2] was injected to achieve a final concentration of 20 µM. The solution was 
then vortexed for 30 seconds, and followed immediately with 20 minutes of bath 
sonication. The hydrogel samples were then allowed to stabilize overnight at 5 °C 
before further study. 
2.2.6. Characterization of NanoGUMBOS: Size and Morphology 
A JEM-1011 (JEOL USA, Inc., Peabody, MA) transmission electron microscope 
was used to obtain micrographs in order to examine the morphology of the prepared 
nanoGUMBOS. Each hydrogel sample was drop-cast (100 µL) onto a TEM grid. Upon 
drying, the grids were washed with water to remove the hydrophilic gels leaving behind 
the hydrophobic nanoparticles. The grids were left to dry before obtaining TEM 
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micrographs. ImageJ was used to determine statistical data on the particles including 
average sizes and standard deviations. 
2.3. Results and discussion 
2.3.1. Characterization of hydrogels 
In order to investigate the use of modified NaDC hydrogels as templates for 
synthesis of nanoGUMBOS and to determine their potential for other applications, 
including material applications, physical characterizations were necessary. Using visual 
observation, it was clear that the hydrogels varied in structural integrity after various 
modifications to TRIS concentration and pH of the medium (Figure 2.1). For example, a 
gel with 25 mM TRIS demonstrated “gel-like” behavior when at pH 5.5. However, the 
same concentration of TRIS at pH 7.4 displayed significant fluidity, or a more “liquid-
like” behavior. In addition, a gel with 300 mM TRIS at pH 7.4 demonstrated “gel-like” 
behavior. Lowering the pH value has been shown to increase NaDC aggregation, 
thereby aiding gelation.38 Therefore, gelation has mostly been reported in acidic 
environments. However, this study demonstrates gelation at the physiological pH for 
higher TRIS concentrations. Thus, it is evident from this study that TRIS is not only 
modifying the gel microenvironment in acidic pH, but is also capable of inducing gelation 
at physiological pH, i.e. above the pKa of NaDC. The morphology and 
microenvironment, as well as thermal and mechanical properties were investigated in 




Figure 2.1. Visual comparison of structural integrity of transparent NaDC hydrogels 
containing blue [HMT][NTf2] nanoparticles prepared at (A) pH 5.5, 25 mM TRIS; (B) pH 
7.4, 25 mM TRIS; and (C) pH 7.4, 300 mM TRIS. 
 
2.3.2. Hydrophobicity and anisotropy studies with fluorescent probes 
Prodan is a neutral, fluorescent, and hydrophobic probe used to evaluate the 
microenvironments of these modified hydrogels. Prodan exhibits a fluorescence 
maximum at about 400 nm in a hydrophobic environment and a maximum at about 530 
nm in a hydrophilic environment.39 Determining the hydrophobicity of the hydrogel 
microenvironment provides information regarding structural changes from one hydrogel 
to another. Examination of the fluorescence spectra of 10 µM Prodan within the 
hydrogels (Figure 2.2), suggested differences in microenvironments. Among hydrogels 
with similar hydrophobicity (as exhibited by the fluorescence spectra) one was selected 
for further studies (Table 2.1). In general, the hydrophilicity of the microenvironment 
experienced by Prodan increased with increasing TRIS concentration. Given the mode 
of gelation, this shows that increasing TRIS concentration leads to an increase in the 
size of aqueous pools formed between the hydrophobic fibers of the hydrogel. This 
trend was not observed for pH 7.4, however, at which each concentration of TRIS had 
approximately the same hydrophobicity with slight variations in intensities. Based on this 
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observation, I suggest that the gel microenvironments at various TRIS concentrations 
are not significantly different at pH 7.4. Based on these data, one TRIS concentration 
was selected from each cluster of intensities for further investigation.  
 
Figure 2.2. Emission spectra of the fluorescent probe Prodan in hydrogels at A) pH 5.5 
and B) pH 7.4. Samples were excited at λex = 360 nm.  
 
The hydrophobicity probe ANS was used to determine the degree of anisotropy, 
or restricted rotation, in each hydrogel. This probe exhibits emission maxima near 430 
nm and 520 nm in hydrophobic and hydrophilic environments, respectively.40 The 
anisotropy of each hydrogel was calculated for both the hydrophobic and hydrophilic 
wavelengths in order to determine the restriction of ANS rotation in the hydrophobic gel 
fibers and the aqueous pools (Figure 2.3). Higher anisotropy values in a hydrophobic 
environment suggest higher rigidity of gel fibers, and higher anisotropy values in a 
hydrophilic environment indicate a smaller water pool between the fibers. This 
rationalization is the result of both a more rigid network and a smaller water pool each 
decreasing the free rotation of a fluorophore, thereby increasing anisotropy. 
Anisotropy studies at 430 nm aid in examining the rigidity of the hydrogel fibers, 
where an increase in anisotropy indicates an increase in rigidity. The anisotropy, and 




with increasing TRIS concentration from -0.23 in the 25 mM TRIS hydrogel to 0.057 in 
the 500 mM TRIS hydrogel. The rigidity of the pH 6.8 gel fibers was also found to 
increase with TRIS concentration with an anisotropy increase from -0.11 to 0.11 from 
the hydrogel with 25 mM TRIS to that with 500 mM TRIS. However, hydrogel fibers at 
the physiological pH value of 7.4 were observed to produce no significant change in 
rigidity with varying TRIS concentration, while exhibiting an average anisotropy of 0.028 
± 0.004. Except at pH 7.4, an increase in TRIS concentration resulted in an increase in 
hydrogel fiber rigidity. 
The sizes of the aqueous pools within the hydrogel network were estimated from 
the anisotropy values at 530 nm. A smaller anisotropy indicated greater rotational 
diffusion of the excited state of the fluorophore and therefore larger pool sizes. 
Examination of these results suggested that the size of the aqueous pools within the pH 
5.5 hydrogels increased at lower TRIS concentrations and decreased at higher TRIS 
concentrations. The 25 mM TRIS and 100 mM TRIS hydrogels exhibited anisotropies of 
-0.058 and -0.029 respectively at the hydrophilic wavelength of ANS. From 200 to 500 
mM TRIS, the anisotropy was found to decrease from -0.033 to -.075. The size of the 
aqueous pools within the hydrogel network at pH 6.8 was found to increase with TRIS 
concentrations. The anisotropy values decreased from 0.10 to 0.062 with increasing 
TRIS concentration from 25 mM to 500 mM. At a pH value of 7.4 with 25, 100, and 200 
mM TRIS, anisotropy of ANS in the aqueous pools of the hydrogels had an average 
value of 0.021 ± 0.008. The higher concentrations of 300 and 500 mM TRIS resulted in 





general, an increase in TRIS concentration resulted in formation of larger water pools 
after gelation. 
 
Figure 2.3. Calculated anisotropies at A) hydrophobic wavelength (430 nm) and B) 
hydrophilic wavelength (520 nm). 
 
2.3.3. Polarized optical microscopy (POM) of modified hydrogels 
The morphology and crystallinity of these hydrogels were characterized by use of 
POM, which is often employed for studies of birefringent materials. This characterization 
yields important information for potential applications of the materials. For example, 
morphology and crystallinity may impact thermal stability, ability to form tough materials, 
use in sensing applications, and use in soft electronics. Figure 2.4 is a compilation of 
polarized optical micrographs of hydrogels at pH 5.5, 6.8, and 7.4 with increasing 
concentrations of TRIS. Hydrogels of pH 5.5 with 25 mM and 200 mM TRIS exhibited 
fibrous structures, while hydrogels with 500 mM TRIS displayed spherulite crystalline 
domains. The increased rigidity of the hydrogels and the appearance of spherulite like 
microstructures at higher TRIS concentrations may be attributed to increased 
crystallinity of the modified hydrogels. This increased crystallinity with increasing TRIS 




concentration, the concentrations of structured hydrogen bond donors and acceptors 
also increased, producing more stability and alignment for the hydrogel network. 
 
Figure 2.4. POM micrographs of pH 5.5, 6.8, and 7.4 hydrogels each with 25, 200, and 
500 mM TRIS. Crystallinity is represented by brightness, and domains were found to be 
amorphous, fibrous, or spherulite in morphology. At pH 6.8 25 and 200 mM and pH 7.4 
25 mM the micrographs were completely black with no apparent crystallinity. 
 
2.3.4. XRD studies 
X-ray diffraction (XRD) studies in conjunction with circular dichroism and quasi-
elastic light scattering have been previously used to show that the structure and 
arrangement of NaDC molecules depend on several conditions including concentration, 
temperature, and salt concentration.38,41 These studies showed that deoxycholate 
aggregates in cylindrical, helical, or spherical patterns are strongly induced as a result 
of hydrogen bonding. XRD studies were performed on hydrogels with 25, 200, and 500 
mM TRIS at each of the three pH values (Figure 2.5) in order to quantify the crystallinity 
of these modified hydrogel structures. Counts obtained through XRD measurements 
have a direct relationship to crystallinity: Higher counts indicate higher crystallinity. 
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Examination of data from these studies confirmed that, in general, the crystallinity of the 
hydrogel increased with TRIS concentration, as visualized using POM.  
For a pH value of 5.5, 25 mM TRIS produced a fairly amorphous hydrogel lacking 
any significant crystalline domains. Evaluation of the 200 mM TRIS hydrogel showed 
relatively intense crystalline planes at 2θ = 10.86° (5877 counts) and 21.7° (4594 
counts). Peaks at these angles correspond to short range spacings of 8.3 and 4.1 nm, 
respectively. The 500 mM hydrogel exhibited several less intense (by an order of 
magnitude, ranging between 100 and 600 counts) crystalline planes between 2θ = 40° 
and 70°.  
 At pH 6.8, hydrogels with 25 and 200 mM TRIS had similar planes of crystallinity 
each at 2θ ≈ 10.7° and 21.5° with about 3300 and 2000 intensity counts, respectively. 
The intensities of these peaks were increased in the 500 mM hydrogel (13000 and 
14400 counts respectively), where several less intense planes also resulted.  
The XRD profile of the 25 mM gel at pH 7.4 revealed an amorphous hydrogel. 
This result is closely aligned with the liquid-like appearance of the hydrogel. The 200 
and 500 mM hydrogels again showed peaks at 2θ ≈ 10.8° and 21.7°, although the 
intensities do not follow the trend observed at other pH values. The intensities of the 
peaks exhibited by the 200 mM hydrogel (27000 and 24000 counts at 10.8° and 21.7°, 
respectively) were about twice as intense as those exhibited by the 500 mM hydrogel 
(about 13000 and 9700 counts at 10.8° and 21.7°, respectively). A pH of 7.4 is well 
above the pKa of NaDC (6.6), resulting in charged, less hydrophobic molecules. This is 
expected to reduce the hydrogen bonding interactions as well as the hydrophobic 
interactions. It is evident from these results that hydrogen bonding is an extremely 
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important factor for increased gel rigidity. Based on these results, it follows that 
hydrogels with different planes of crystallinity should provide different templates for 
nanoparticle synthesis and thus can be exploited for such applications. 
 
Figure 2.5. X-ray diffraction patterns of A) 25 mM TRIS and B) 500 mM TRIS, where 
increased counts indicate increased crystallinity.   
2.3.5. DSC studies 
Sol-gel transitions are endothermic events and can, therefore, be measured 
using DSC.42 Endothermic transitions are represented by a significant decrease in 
measured heat flow. The sol-gel temperature of this system was found to increase with 
TRIS concentration, which is considered the result of increased crystallinity and network 
stability.43 In this study, the sol-gel transition temperatures of the hydrogels were tuned 
from about 35 °C to about 65 °C (Table 2.2). Such a property could be extremely useful 
for in situ applications in that a hydrogel system could be selected to undergo or to 
avoid a sol-gel transition during an experiment. For example, a sol-gel temperature 
above 37 °C would allow a hydrogel to be used in vivo as artificial tissue or an 





Table 2.2. Sol-gel transition temperatures of gels as measured by differential scanning 
calorimetry. (Note: Due to the high water content and lack of covalent bonding, specific 
protocols were developed for each sample. An appropriate methodology could not be 
found for DSC analysis of these (*,**) gels. However, a sol-gel transition was visually 
observed between 50 and 60 °C for each of the three * samples and slightly above 




Measurements provided by use of DSC were also confirmed by visual 
observations of the gels in a water bath of gradually increasing temperature. An 
approximate temperature was recorded when a sample no longer appeared to have a 
gelatinous consistency. For example, the visually observed sol-gel temperature for pH 
6.8, 50 mM (as seen in Table 2.2) was about 35 °C, compared to the DSC 
measurement of 36 °C (Figure 2.6). Increased sol-gel temperature with increased TRIS 
concentration confirmed the XRD and POM findings of increased crystallinity and rigidity 



























Figure 2.6. DSC thermogram of a hydrogel of pH 6.8 and 50 mM TRIS. The sharp 
decrease at 36 °C indicates a sol-gel transition. This closely corresponds to a visually 
observed transition at approximately 35 °C. 
 
2.3.6. Rheology 
Rheological studies are typically performed in order to examine the viscoelasticity 
of hydrogels.45 Such studies are important for understanding the utility of these gels for 
various applications. For instance, high mechanical strength hydrogels can be useful for 
materials applications.46 The storage modulus (G’) and the loss modulus (G”) were 
determined for each sample as a function of angular frequency (rad/s). Each hydrogel of 
this study had a particular shear rate after which the G’ and G” showed erratic behavior. 
This is the shear rate at which there is enough mechanical stress placed on the 
structure of the gel such that it began to have greatly increased fluidity. This is 
commonly referred to as “breaking” the gel.47 For pH values of 6.8 and 7.4, both the G’ 
and G” showed a break at shear rates that increased with increasing concentrations of 
TRIS. This further supports the theory that increasing the TRIS concentration increases 























trend as well, with the breaking rate increasing from 28.6 rad s-1 to > 63 rad s-1 when the 
TRIS concentration increases from 25 to 500 mM. However, the G’ does not follow an 
observable trend, which suggests a more complicated gelation mechanism. This 
observation is also complementary to fluorescence anisotropy results for the 
hydrophobic gel fibers where no regular trend was observed at this pH. The increase in 
fluidity that occurs during breaking lends to potential use of these hydrogels as drug 
delivery systems.48 In addition, gels with high rigidity have potential utility for use in 
biotechnology applications such as artificial tissues.49  
Under shear stress, a unique behavior was observed in several of the hydrogels 
in this study, namely pH 5.5: 200, 250, and 300 mM TRIS; pH 6.8: 200 mM TRIS; and 
pH 7.4: 300 mM TRIS (Figure 2.7 A-E). A plot of storage modulus versus shear 
frequency yielded two stable regions as opposed to the generally observed single 
region. In cases where no data are shown between the two stable regions (Figure 2.7 B, 
C, and E), the G’ exhibits an erratic behavior indicative of a broken gel in the omitted 
region. Presence of two stable regions in the elastic modulus indicated that there are 
two ranges of shear frequency in which the hydrogels form stable structures. To the 
best of our knowledge, such a behavior has not been previously observed and yields 
exceptional potential for applications in injectable drug delivery.50,51 Preliminary work 
was done to investigate this potential, and both hydrogel formulation and shearing seem 
to significantly affect drug release (Figure 2.7 F), warranting further investigation. 
 
2.3.7. Characterization of hydrogel-templated nanoGUMBOS and microGUMBOS. 
Modifications to the NaDC hydrogels, including changes in TRIS concentration 
and pH, led to tunable size variations of nano- and microGUMBOS formed therein 
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(Table 2.3). All nano- and microGUMBOS in this study are NIR dyes with potential 
applications in biological imaging. NanoGUMBOS formed in pH 5.5 hydrogel templates 




Figure 2.7. A-E: Rheograms (G’) showing two distinct hydrogel structures at different 
ranges of shear rates. A) pH 5.5, 200 mM TRIS; B) pH 5.5, 250 mM TRIS; C) pH 5.5, 
300 mM TRIS; D) pH 6.8, 200 mM TRIS; and E) pH 7.4, 300 mM TRIS. F: Release of 
fluorescein from several formulations. The green bars correspond to release from gels 


















































































25 57 ± 6 
100 46 ± 8 
200 44 ± 8 
250 72 ± 14 
300 809 ± 150 
500 8 ± 1 
6 
25 76 ± 6 
200 48 ± 11 
300 21 ± 4 
500 19 ± 4 
6.8 
50 33 ± 9 
100 62 ± 29 
200 209 ± 35 
400 30 ± 4 
7.4 
25 154 ± 26 
100 221 ± 58 
300 312 ± 58 
 
observed with increasing TRIS concentration. For example, the size of [HMT][NTf2] 
remained almost constant at 50 nm with increasing TRIS concentration between 25 and 
200 mM. At 250 mM TRIS, such nanoGUMBOS slightly increased in size to 72 ± 14 nm 
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with even greater increases at 300 mM TRIS (microGUMBOS of 809 ± 150 nm). 
Additional increases in TRIS concentration to 500 mM led to a significant decrease in 
size of the nanoparticles to 8 ± 1 nm.  
Hydrogels immobilized at pH 6.0 with 25 mM TRIS yielded [HMT][NTf2] 
nanoparticles with an average size of 76 ± 6 nm (Figure 2.8A). This is effectively the 
same size as nanoparticles produced under similar conditions with the GUMBOS 
[HMT][AOT].7 TRIS concentrations of 200 mM, 300 mM, and 500 mM resulted in 
respective particle sizes of 48 ± 11, 21 ± 4 nm, and 19 ± 4 nm (Figure 2.8 B-D). The 
size of the [HMT][NTf2] nanoparticles were found to decrease with increasing TRIS 
concentration. This trend was the reverse of that found with [HMT][AOT] studies where 
particle size was found to increase with TRIS concentration. 
 
Figure 2.8. TEM micrographs of [HMT][NTf2] nanoGUMBOS as templated by pH 6 
hydrogels with A) 25 mM TRIS, B) 200 mM TRIS, C) 300 mM TRIS, and D) 500 mM 







Contrasting trends found in nanoGUMBOS with [NTf2] and [AOT] anions is 
believed to be a result of the relative hydrophobicities as determined by octanol/water 
partition coefficients (Poct/wat). Hydrophobicity of [NTf2] is significantly greater than that of 
[AOT] with respective koct/wat values of 14.8 and 1.65. NanoGUMBOS with an even 
greater hydrophobicity (koct/wat=29.9), [HMT][TPB], were templated in pH 6.0 gels to 
confirm this theory. While the [HMT][TPB] nanoGUMBOS increased in size with an 
increase in TRIS, the particles had a wider range in size than did either of the other two 
GUMBOS investigated. From 25 to 500 mM TRIS, the [HMT][TPB] particles increased 
from 3.6 ± 0.5 to 257 ± 56 nm, indicating that particle size is material-dependent. 
However for a given material a definite trend in size was observed suggesting the 
applicability of these modified hydrogel systems for size-controlled synthesis of 
nanoparticles. 
While the [HMT][NTf2] nano- and microGUMBOS resulting from pH 6.8 templates 
did not follow an obvious trend in size, the sizes are consistent with the anisotropy 
studies performed on these gels. In smaller aqueous pools such as with 50 mM and 400 
mM TRIS, the particles were 33 ± 9 nm and 30 ± 4 nm respectively. The largest 
aqueous pool of this pH formed the largest particles, i.e. 200 mM TRIS hydrogel forming 
209 ± 35 nm particles. Pools of intermediate size, found in the 100 mM TRIS hydrogel, 
templated nanoGUMBOS of an intermediate size, i.e 62 ± 29 nm. This again suggests 




At pH 7.4, most particles were significantly larger than at other pH values and 
generally increased in size with increasing TRIS concentration from 154 ± 26 nm to 312 
± 58 nm with TRIS concentrations of 25-300 mM. 
2.4. Conclusions 
In conclusion, I have developed multiple new NaDC/TRIS hydrogel materials 
through variation of TRIS concentration within fixed pH values. These new materials 
were characterized and evaluated for nanosynthesis and drug delivery applications. 
Modification of the hydrogels led to a broad range of attainable properties. 
NanoGUMBOS of three NIR dyes were templated using hydrogels, and the resulting 
nanoparticle size was concluded to be material dependent and governed by the gel 
microstructure and rheological characteristics. As evidenced by anisotropy calculations, 
POM, and XRD characterization, pH and TRIS concentration within a given pH play an 
extremely important role towards crystallinity and structural rigidity of the hydrogels. 
Tunable crystallinity resulted in tunable sol-gel transition temperatures between slightly 
above room temperature and 63 °C, as measured by DSC and visually observed. 
Rheological studies showed that these designer hydrogels have tunable mechanical 
properties that could be suitable for bioengineering and drug delivery applications. 
Tunability was found in hydrogels immobilized at the physiological pH value, further 
demonstrating suitability in biological applications.  
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CHAPTER 3.  
SODIUM DEOXYCHOLATE/TRIS-BASED HYDROGELS FOR 
MULTIPURPOSE SOLUTE DELIVERY VEHICLES: AMBIENT RELEASE, 
DRUG RELEASE, AND ENANTIOPREFERENTIAL RELEASE* 
 
3.1. Introduction 
The study of controlled and sustained drug release vehicles has been a topic of 
increasing attention over the past several decades. Delivery vehicles are widely applied 
in many fields ranging from food production to agriculture to pharmaceuticals.1 Drug 
delivery vehicles, specifically, are rapidly gaining importance as the focus of drug 
development shifts from small molecules to macromolecular biologics.2 Biologics require 
higher delivery concentrations,3 more protection from metabolic interactions,4 and more 
targeted delivery than small molecule drugs.5 Due to these requirements, more 
sophisticated delivery vehicles are needed.  Hydrogels are often selected as drug 
delivery vehicles because of similarities to biological membranes6 and beneficial 
characteristics7 including high water content relative to other materials,8 
biocompatibility,9 biodegradability,10 stimuli-responsiveness,11 and high porosity.12 Low 
molecular weight (LMW), physical hydrogels have the benefits of facile processing13 and 
lower toxicity due to the absence of crosslinkers.14  
Hydrophobic domains within a hydrogel network can be used to increase 
 
* This chapter previously appeared as “McNeel, K. E., Siraj, N., Negulescu, I., & 
Warner, I. M. Sodium deoxycholate/TRIS-based hydrogels for multipurpose solute 
delivery vehicles: Ambient release, drug release, and enantiopreferential 




loadable drug concentration because most pharmaceuticals have low water 
solubility.7,15,16 Hydrogel matrices are often used to protect drugs, specifically biologics 
such as proteins and antibodies, until the target is reached.4 Injectable hydrogels are 
also often used for biologics to provide more targeted delivery. Protection of drugs also 
lowers the necessary dosage by reducing dilution of the drug in the body and retaining 
elevated local concentration through slow release.7 Furthermore, frequency of 
administration can be reduced through the use of a hydrogel exhibiting sustained 
release properties.17  
In addition to the rising number of biologic drugs, more than half of the molecular 
drugs on the market are chiral and exist as a mixture of enantiomers, making chirality 
an important consideration in the pharmaceutical industry.18 In many cases, one 
enantiomer is less active than the other, making separation of enantiomers beneficial. In 
more severe cases, one enantiomer exhibits toxicity, which highlights the importance of 
enantiomeric separations. In order to formulate a pharmaceutical with a single 
enantiomer, a separation method such as chromatography or capillary electrophoresis 
is typically employed.19,20,21 When these traditional methods of separations 
(chromatography, electrophoresis) are employed, enantiomeric separation must occur 
offline before the separated drug can be administered, thereby increasing cost and time 
for pre-processing. An ideal solution would involve racemic drug loading (i.e. equal 
amounts of each enantiomer) into a delivery vehicle from which only one enantiomer 
would be released.22 Over the past decade, a few enantio-selective release hydrogels 
have been designed using a variety of methods and polymeric or LMW gelators. For 
example, Suedee et al. reported on chitosan-based transdermal patches for selective 
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delivery of S-propranolol.23 This group later developed a pH-responsive system 
composed of poly(hydroxyethyl methacrylate) and polycaprolactone-triol for selective 
delivery of S-omeprazole.24 In 2014, Suksuwan et al. demonstrated selective release of 
R-thalidomide from a polymer network composed of methacrylic acid, 2,6-
bis(acrylamido)pyridine, and N,N’ methylene-bis-acrylamide.25 All three of these 
systems have excellent functionality in delivering the desired enantiomer. However, in 
all cases, synthesis of such systems required many steps, inclusive of chemical 
modification, polymerization, and molecular imprinting. Each of these steps takes 
technical ability and significant analysis, increasing the time and cost of development 
and production. 
The Warner research group has recently studied the tunability of sodium 
deoxycholate (NaDC)/ tris(hydroxymethyl)aminomethane (TRIS) hydrogel systems.26,27 
Mechanical properties, sol-gel temperature, and release propeties were found to be 
tunable with modifications to pH and TRIS concentration. In the current study, I extend 
the preliminary findings of the previous work to explore the drug delivery capabilities of 
NaDC/TRIS hydrogels using model drugs of variable molecular weight and chirality. 
Analytes include fluorescein (a small molecule), bovine serum albumin (a 66 kDa 
protein), and the chiral molecules tryptophan and ibuprofen. The effect of shearing on 
the release of solutes was examined in order to simulate injection, as in subcutaneous 
drug delivery. Furthermore, other variables such as temperature, drug concentration, 
and hydrogel formulation were also explored as parameters affecting drug release. 
Each of these variables can be varied to tune drug release, indicating the broad 
tunability of NaDC/TRIS hydrogels as solute delivery systems. The specific application 
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of enantio-preferential drug release was examined in detail through release of both 
enantiomeric forms of model drugs. This NaDC/TRIS hydrogel system is a facilely 
synthesized, inexpensive candidate for injectable and enantio-selective drug delivery.  
3.2. Materials and methods 
3.2.1. Materials 
Sodium deoxycholate (NaDC) (≥ 97%), tris(hydroxymethyl)aminomethane (TRIS) 
(≥ 99.9%), fluorescein sodium salt (≥ 97.5%), bovine serum albumin (BSA) (≥ 96%), α-
lactalbumin (αLB) (≥ 85%), (S)-(+)-ibuprofen (≥ 99%), L-phenylalanine (≥ 98%), and L-
tryptophan (≥ 98%) were purchased from Sigma Aldrich. (R)-(-)-ibuprofen (≥ 98%) was 
obtained from Enzo Life Sciences. D-phenylalanine (≥ 99.9%) and D-tryptophan (≥ 98%) 
were obtained from Bachem. γ-Cyclodextrin (≥ 98%) was obtained from Fluka. All 
chemicals were used as received. Triply deionized water (18 MΩ cm) was obtained from 
an Aries Filterworks high purity water system and used for all experiments. 
3.2.2. Hydrogel selection and synthesis 
Aqueous TRIS buffer solutions were prepared at 200, 250, and 300 mM. By use 
of hydrochloric acid, each TRIS solution was adjusted from an initial native pH value 
greater than 10 to an acidic pH value of 5.5. Solutions of 200 mM TRIS were also 
adjusted to a pH value of 6.8, generating a total of four formulations. These conditions 
of pH value and TRIS concentration were chosen because they were previously found 
to yield interesting rheological properties.27 NaDC was added to the TRIS buffer 
solutions as a solid to produce a final concentration of 20 mM. NaDC addition was 
followed immediately with 30 seconds of vortexing and 20 minutes of bath sonication. 
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After sonication, samples were left to stabilize at 5 °C overnight before analyses. For 
drug delivery applications, it is useful to note that gelator is less than 1% of the system 
by weight. The hydrogel is composed of a maximum 6% TRIS (at 500 mM), while the 
remaining ≥ 93% is water. 
3.2.3. Swelling Measurements 
Swelling ratio is an important characteristic of hydrogel drug delivery vehicles 
due to drug loading and in vivo behavior dependence on these values. In order to 
measure swelling ratios, hydrogels were synthesized as previously outlined. Excess 
water was added to each gel after overnight stabilization, and samples were left to 
equilibrate for a week. After one week, any excess water not immobilized by the 
hydrogel was removed (leaving ms). Dried gels were obtained by leaving exposed 
hydrogel samples in a desiccator (md). Swelling ratio was calculated as follows: 
	  
where ms is the mass of the swollen hydrogel and md is the mass of the dry sample. 
3.2.4. Viscoelastic measurements 
A TA AR 1000 rheometer (TA Instruments, Inc., Waters Corp., New Castle, DE) 
with stainless steel plate geometry was used to investigate the rheological properties of 
these hydrogels, specifically the G’ and G” moduli. This rheometer was also used to 





3.2.5. Solute release measurements 
Solute release measurements were performed using sets of identical hydrogels 
to measure different parameters within the same experiment. For example, if solute 
release was measured after one hour and after six hours, two hydrogels were prepared 
(one for each time of interest). At fixed time intervals, drug release was monitored by 
use of the absorbance of the supernatant. Absorbance was measured using a UV-vis-
near-IR scanning spectrometer (Shimadzu, Columbia, MD). A 4 mm path length quartz 
cuvette (Starna Cells) was used for absorbance measurements with an identical cuvette 
filled with phosphate buffer as a blank. Fluorescein concentration was calculated using 
a linear calibration curve. Model drugs based on proteins and amino acids (BSA, α-
lactalbumin, tryptophan) were analyzed at the absorbance wavelength of 280 nm. 
Ibuprofen was analyzed at 210 nm. Release experiments were performed at two 
different temperatures as noted with the corresponding data. All tryptophan and 
ibuprofen release experiments were performed at 37 °C. Room temperature 
experiments were performed under purely benchtop conditions. Experiments at 37 °C 
were performed in a temperature controlled incubator. 
3.3. Results and discussion 
3.3.1. Swelling capacity of hydrogels 
Diffusion of drugs and other solutes from a hydrogel network is due in large part 
to the swelling capacity of the hydrogel system. Generally, an increased swelling ratio 
results in increased drug release. In the case of NaDC/TRIS-based hydrogels, swelling 
ratio was found to be dependent on TRIS concentration of hydrogel formulation (Table 
3.1). Interestingly, the calculated swelling ratio decreased with increasing TRIS 
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concentration at pH 5.5. Hydrogels of pH 5.5, 200 mM TRIS had swelling ratios of 72.9 
± 0.9. An increase in TRIS concentration to 250 mM at pH 5.5 resulted in a significantly 
decreased swelling ratio of 57.0 ± 0.4. A further increase in TRIS concentration (i.e. to 
300 mM) resulted in a smaller decrease in swelling ratio to 50.6 ± 0.2. Since TRIS has 
hydrogen bonding sites, it is likely that increased TRIS concentration reduced swelling 
by physically crosslinking the hydrogel to a further degree at higher concentrations. 
Previous work has also shown that this increase in [TRIS] enhanced the crystallinity, 
further supporting that increased [TRIS] restricted the hydrogel swelling. 
Table 3.1. Swelling ratio of hydrogels with varied TRIS concentration 
 
3.3.2. Viscoelasticity of solute-loaded hydrogels 
I previously reported that several formulations of NaDC/TRIS-based hydrogels 
exhibit a unique rheological behavior.27 The elastic modulus (G’) of these materials 
showed two stable regions instead of the typical single region. The presence of two 
stable regions is interpreted as a rearrangement of internal gel structure upon 
application of sufficient shear rate.  
Sun and colleagues28 observed that the addition of certain amino acids to sodium 







sol transition. Since many target molecules for injectable systems are composed of 
proteins, it is of the utmost importance that this system retains its viscoelasticity upon 
addition of proteins. Figure 3.1A shows the elastic moduli of hydrogels of pH 5.5, 300 
mM TRIS with 0, 1, 10, and 50 mg/mL BSA. As shown in this figure, increases in BSA 
concentrations (from 0-50 mg of BSA per mL of hydrogel) did not significantly change 
the observed elastic modulus of hydrogels within the range of angular shearing 
frequencies examined. It is important to note that the presence of two stable elastic 
regions is retained at all protein concentrations examined. The retention of viscoelastic 
properties with addition of BSA indicated that these hydrogels are good candidates for 
protein delivery systems.  
 
Figure 3.1. Angular frequency vs. G’, storage modulus, of hydrogels pH 5.5 and 300 
mM TRIS A) Four concentrations of BSA, i.e. 0, 1, 10, and 50 mg/mL. B) 3 proteins 
loaded at 10 mg/mL. 
Three proteins of varying sizes were loaded into hydrogels of pH 5.5, 300 mM at 
10 mg/mL (viz. cytochrome c – 12 kDa, α-chymotrypsinogen – 25.6 kDa, transferrin – 







































from those of native (i.e. non-loaded) hydrogels (Figure 3.1B). The unchanged moduli 
suggest that the hydrogel structure is highly resilient and can be used with a wide 
variety of loaded protein drugs. 
3.3.3. Fluorescein release: effect of shearing, hydrogel formulation, loaded 
concentration, and temperature 
Small molecule solutes, such as dyes, are often desirable for sustained release 
applications. The release of a small solute, fluorescein, was examined from sheared 
and non-sheared hydrogels of pH 5.5, 300 mM TRIS at room temperature and at 37 °C 
in order to analyze utility of this hydrogel system as a drug delivery vehicle (Figure 3.2). 
At room temperature, sheared and native gels completed fluorescein release in 
approximately 6 hours. Shearing resulted in a significant increase of total fluorescein 
released. Maximum release of fluorescein was increased from 175 µM to 303 µM, i.e. 
almost double. Disodium salt of fluorescein has significant water solubility. It is likely 
that upon shearing, the hydrogel structure becomes more porous in such a manner that 
fluorescein diffuses out in greater quantity. This significant increase in fluorescein 
release is critical to applicability of this system. To the best of our knowledge, this 
shearing effect on solute release has not been previously explored. The significant 
difference in release indicates that the mode of application (i.e. whether or not the 
hydrogel will be sheared before desired release) must be taken into consideration when 
calculating solute loading versus solute dosing concentrations for ambient temperature 
release. 
 Release of fluorescein at 37 °C was similarly found to plateau in ~6 hours (Figure 




Figure 3.2. Release profiles of 500 µM disodium fluorescein from pH 5.5, 300 mM TRIS 
hydrogels that had and had not been sheared. A) Release at room temperature B) 
Release at 37 °C  
release. Within the first hour, sheared hydrogels released significantly more fluorescein 
than a hydrogel that had not been sheared. As seen with room temperature release, 
shearing likely disrupted the crystalline packing of the hydrogel structure, which 
consequently lessened the hindrance of fluorescein release. At later time intervals, the 
difference was no longer as significant. However, within a single trial, sheared release 
was always higher than non-sheared release. Over longer periods of time at 37 °C, 
crystallinity of hydrogel structure likely began to reform (i.e. self-repair) from the 
disruption of shearing as evidenced by similarity in released fluorescein from sheared 
and non-sheared hydrogels at later times. The majority of release occurred within the 
first three hours, indicating that these materials are not suitable for prolonged release (> 
6 hours) in their current form. For release over shorter time periods (< 6 hours) the 
mode of application (sheared or not) should still be considered. Long-term release 























































°C. Thus, final solute release must be determined based on whether or not a shearing 
force will be applied to the gel before desired release and the temperature at which 
release will occur. 
Three hydrogel formulations were investigated as sustained release vehicles. 
Specifically, solutions immobilized at a pH value of 5.5 were evaluated with three 
different TRIS concentrations, viz. 200 mM, 250 mM, and 300 mM. Increases in TRIS 
concentration has been previously shown to increase crystallinity of the materials, which 
may itself impact release.26,27 As expected, formulation was determined to significantly 
affect total fluorescein release at room temperature (Figure 3.3A). It was found that at 
pH 5.5, an increase in TRIS concentration decreased the total amount of fluorescein 
released from hydrogels that had not been sheared. This decrease closely followed the 
decreased swelling ratio found between these hydrogel formulations. The decrease in 
fluorescein release also suggested that the closely related parameter of crystallinity 
impeded solute release. Interestingly, it was found that increased TRIS concentration 
also resulted in an increase of total fluorescein released from hydrogels that had been 
sheared. It is possible that shearing disrupted the crystalline packing of these materials, 
thereby reducing the impediment on solute release. Interestingly, at 37 °C average 
release of fluorescein decreased with increasing TRIS concentration (Figure 3.3B). As 
was seen at room temperature, decreased fluorescein release from gels that had not 
been sheared paralleled the decrease in swelling ratio. Unlike at room temperature, this 
trend was seen in both gels that had and had not been sheared. The decrease in 
amount of fluorescein released was likely due in part to crystallinity of the samples. 
While shearing is thought to disrupt crystallinity in these materials, examination of these 
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data suggested that at 37 °C, hydrogels reformed crystalline packing. Therefore, the 
amount of solute released from a hydrogel could be tuned simply by changing TRIS 
concentration when the mode (sheared or not) and temperature of delivery are known. 
The ease of this tunability is exceptionally useful for the applicability of this system.  
 
Figure 3.3. Effect of TRIS concentration in pH 5.5 hydrogels on release of fluorescein at 
A) room temperature B) 37 °C. 
Several concentrations (viz. 100, 300, 500, 700, and 1000 μM) of fluorescein 
were loaded into hydrogels of pH 5.5, 300 mM. Total release at 37 °C was measured 
via absorbance after the plateau of release. A linear correlation was found between an 
increase in the concentration of fluorescein loaded and an increase in fluorescein 
released (Figure 3.4). Final concentration released was found to increase from 48.02 ± 
18.03 μM (non-sheared) and 69.88 ± 32.29 μM (sheared) in gels loaded with 100 μM 
fluorescein to 458.00 ± 32.14 μM (non-sheared) and 449.30 ± 20.15 μM (sheared) in 
gels loaded with 1000 μM fluorescein with a linear correlation of R2 = 0.98. This linear 
























































necessary loading concentration to easily be calculated when the required dosage is 
known. 
 
Figure 3.4. Total release of fluorescein from pH 5.5, 300 mM TRIS hydrogels at 37 °C 
when loaded with 100-1000 μM fluorescein. 
3.3.4. BSA release: effect of shearing, hydrogel formulation, loaded 
concentration and temperature 
Large molecules, often proteins and other biologics, are also useful as released 
agents from hydrogels. In order to examine the release of proteins, BSA –a protein of 
66 kDa– was chosen as a large model solute. At room temperature, shearing of the 
hydrogel material had the opposite effect on this large solute than on the small solute 
fluorescein (Figure 3.5). At shorter time intervals (< 6 hours), BSA was released less 
from gels that had been sheared than from gels that had not been sheared. At longer 
time intervals (24-72 hours), there was no longer a significant difference in BSA release 























through hydrophobic interactions and hydrogen bonding. This hydrogel formulation 
employed an acidic solution (pH 5.5) which may slightly denature BSA. Since BSA has 
many hydrophobic domains and hydrogen bond donors and acceptors, it is possible that 
applying a shear force to the gel may have increased protein/hydrogel interaction 
density. Shearing therefore inhibited initial release of BSA. Similarity of release at longer 
time intervals further supported the theory that the hydrogel network self-repairs after 
shearing. 
Pharmaceutically relevant concentrations of protein-based drugs are typically 
between 10 and 100 mg of protein per mL of delivery matrix. For many hydrogel 
delivery systems, loading such a high concentration of protein is not feasible because 
drug loading is done through sorption or because such concentrations lead to a reversal 
of gelation. In the case of this NaDC/TRIS hydrogel system, solute loading occurs 
concurrently with gelation. Thus, protein is added to the buffer solution before gelator is 
added and before gelation begins. The result of this concurrent gelation is that high 
concentrations of protein can be added without disruption of the hydrogel structure. This 
high loading is of paramount importance to the true applicability of a hydrogel delivery 
system.  
BSA was loaded to 50 mg/mL for examination of its release at 37 °C. It was 
found that at many time intervals, BSA was released more from gels that had been 
sheared than from gels that had not been sheared (Figure 3.7). However, at 24 and 72 
hours, the release is not significantly different. At room temperature, shearing was found 
to decrease BSA release. Shearing increased release of BSA at 37 °C, indicating that 
increased temperature weakened hydrogen bonding sufficiently for BSA release to be 
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increased. Increased release was due to a more porous hydrogel network as seen in 
fluorescein release. However, the convergence of release profiles at 24 and 72 hours 
showed that release was controlled by multiple factors. Reforming of the hydrogel 
network apparently incorporated some the released BSA back into the hydrogel network 
(see decreased total release at 24 hours). It can be concluded that the type of hydrogel 
application (sheared or non-sheared) and the desired time of release should be 
considered when calculating loading and dosing concentrations for this set of 
conditions. 
  
Figure 3.5. Release profiles of BSA from pH 5.5, 300 mM TRIS hydrogels that had and 
had not been sheared A) Room temperature release (loaded to 1.3 mg/mL) B) 37°C 
release (loaded to 50 mg/mL). 
Three formulations of NaDC/TRIS hydrogels were examined in order to analyze 
the effect of modification on the release of BSA at room temperature (Figure 3.6A) and 
at 37 °C (Figure 3.6B). In the case of hydrogels of pH 5.5 with 200 mM TRIS, shearing 
significantly lowered the amount of BSA released at room temperature. This lower 














































increased effect of shearing. However, hydrogels of pH 5.5 with 250 mM and 300 mM 
TRIS did not yield a significant difference in BSA release from gels that had and had not 
been sheared. There is not a direct relationship between BSA released at room 
temperature and TRIS concentration. Hydrophobic domains and hydrogen bonding sites 
of BSA interacted with the hydrogel network resulting in a complex release mechanism. 
Therefore, hydrogel formulation and mode of application must both be considered 
before calculating solute loading concentrations of large molecules. Tunability of 
hydrogel formulation may still be utilized in cases where total release is not significantly 
affected. For example, the mechanical strength of a hydrogel of pH 5.5, 300 mM TRIS 
may be required for a specific application, while the final release of a pH 5.5, 200 mM 
TRIS hydrogel is known to be appropriate. In this case, hydrogel formulation can be 
altered without significantly changing solute release. Thus, the tunability in hydrogel 
properties, including amount of drug release and sol-gel temperature, can be used to 
design a hydrogel system which is well-suited to a particular application. 
The total amount of BSA released at 37 °C was consistent between formulations 
and between gels that had and had not been sheared within a formulation. Thus, it is 
likely that BSA released at 37 °C was primarily diffusion controlled at long time intervals. 
This consistency in release can be very desirable for clinical application because 
hydrogel formulation can then be used to tune other properties of the hydrogel (e.g. 




Figure 3.6. Comparison of BSA release from three hydrogel formulations that had and 
had not been sheared at A) room temperature and B) 37 °C. 
Although pharmaceutically relevant concentrations of protein-based drugs are 
typically between 10-100 mg/mL, sustained release applications for food and agriculture 
often have substantially lower concentration requirements. For this reason, release 
profiles at three different concentrations of loaded BSA were examined (Figure 3.7). As  
 


































































was determined with fluorescein, final release of BSA was found to increase with 
concentration of BSA loaded into the gel. BSA is known to be water soluble up to 40 
mg/mL. A similar proportionality between concentration of solute loaded and amount of 
solute released suggested that solute release is not strongly dictated by solubility. This 
is an extremely useful property due to the low water solubility of many pharmaceuticals 
(especially biologics) and other desired solutes. 
3.3.5. Release of three proteins at room temperature 
Release of three model protein solutes of varied sizes, viz. cytochrome c (12 
kDa), α-chymotrypsinogen (25.6 kDa), and transferrin (80 kDa) were analyzed from 
sheared and non-sheared hydrogels at room temperature. It was found that the effect of 
shearing a hydrogel varied significantly between different solutes (Figure 3.8). 
Cytochrome c (12 kDa) and transferrin (80 kDa) exhibited similar release. Sheared and 
non-sheared hydrogels exhibited significant release of both cytochrome c and 
transferrin proteins. Release from sheared hydrogels was slightly greater for both 
proteins. This is comparable to observed BSA release, indicating that protein size is not 
a primary factor in release. Notably, α-chymotrypsinogen (25.6 kDa) exhibited 
significantly lower release from non-sheared than from sheared hydrogels. While 
cytochrome c, transferrin, and (to a lesser extent) BSA are all somewhat water soluble 
(i.e. 40-200 mg/mL), α-chymotrypsinogen is only sparingly soluble. Therefore, without 
occurrence of shearing, the hydrogel network was a highly favorable environment for α-
chymotrypsinogen. Upon shearing, however, α-chymotrypsinogen exhibited comparable 
release to other proteins examined. Therefore, in cases where desired solutes are not 
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water soluble, a sheared application (such as injection) could be used to stimulate 
release. 
 
Figure 3.8. Release profiles of cytochrome c (12 kDa), α-chymotrypsinogen (25.6 kDa), 
and transferrin (80 kDa) from pH 5.5, 300 mM TRIS sheared and non-sheared 
hydrogels.  
3.3.6. Enantio-preferential release of D-tryptophan at 37 °C 
NaDC has long been known to form chiral micelles in aqueous solutions.29,30 
Tryptophan was chosen as a model chiral drug for investigating the chirality of 
NaDC/TRIS hydrogels. Hydrogels loaded with 5 mM L- or D- tryptophan released D-
tryptophan with remarkable enantio-preference (Figure 3.9). D-tryptophan was 
substantially released from the hydrogel, while L-tryptophan had approximately zero 
release. Complete retention of one enantiomer is immensely desired in the case of 
molecules with a toxic enantiomer. It is useful to note that the enantio-preference of D-
tryptophan released was from the native gel state with no additional chiral selectors or 
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modifiers. Known chirality of NaDC micelles was therefore retained or enhanced in 
formation of NaDC/TRIS hydrogels. Net chirality of the hydrogel network thereby 
facilitated enantio-preferential release of D-tryptophan. 
 
Figure 3.9. Absorbance of L- and D- tryptophan released from a hydrogel system at 37 
°C. 
3.3.7. Ibuprofen release: effect of loaded concentration and enantio-inversion 
In addition to high water content and sustained release properties, hydrogels can 
also be useful to pharmaceutical applications due to the presence of hydrophobic 
domains in the hydrogel network. Although the human body is primarily an aqueous 
environment, most pharmaceuticals are water insoluble. The hydrophobic domains of a 
hydrogel can help to suspend hydrophobic drugs (if not dissolve them) and prevent 
crystallization and precipitation. In this regard, hydrogels can enhance bioavailability of 
drugs. 
Ibuprofen, a common chiral analgesic, has very low water solubility (102 µM at 



















preferential release system with the inherent benefit of hydrophobic domains in hydrogel 
delivery systems. Figure 3.10A shows the release of R- and S-ibuprofen at two different 
concentrations, viz. the maximum water soluble concentration (102 µM) and ten times 
the maximum water soluble concentration (1020 µM). Despite loaded concentration 
extending well beyond water solubility, enantio-preference was not lost in ibuprofen 
release. Chirality of the hydrogel network should be unaffected by loaded ibuprofen. 
Despite lack of solubility in water, ibuprofen was sufficiently dispersed throughout the 
hydrogel network to sample network chirality. Preservation of enantio-preferential 
release well above the level of solubility is of the utmost importance for practical use of 
NaDC/TRIS hydrogels as enantio-preferential drug delivery vehicles due to the low 
solubility of many pharmaceuticals. 
 Perhaps the most significant finding presented here is the ability to invert the 
enantio-preference of this release system. I found that through the addition of 5 mM γ-
cyclodextrin to the hydrogel matrix, enantio-preference was reversed (Figure 3.10B). 
That is, with the addition of 5 mM γ-cyclodextrin, S-ibuprofen (loaded at 97 µM) was 
preferentially released. This preference was opposed to the preferential release of R-
ibuprofen from the native gel. The amount of R-ibuprofen released from a native gel had 
an absorbance of 0.44 ± 0.039, whereas release from a gel with 5 mM γCD had an 
absorbance of 0.27 ± 0.0066. S-ibuprofen was quantitatively opposite. It was released 
to an absorbance of 0.24 ± 0.021 from a native gel and 0.49 ± 0.0075 from a gel with 5 
mM γCD. Since γCD was added to the solution prior to gelation, it is likely incorporated 
into the hydrogel network upon gelation through hydrogen bonding, hydrophobic 
interactions, and other non-covalent interactions. Incorporation of γCD seemingly 
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reversed net chirality of the network in such a manner as to sufficiently reverse enantio-
preference. Further investigation of this interesting quantitative similarity of enantiomeric 
releases may yield more information on the mechanism of the enantio-preferential 
release process. 
Enantio-preference inversion is extremely significant due to the fact that the 
desired enantiomer may not be the enantiomer released from a native gel. For example, 
the S enantiomer may be beneficial while the R enantiomer is the one preferentially 
released. This monumental finding of facile enantio-inversion can greatly reduce the 
time, cost, and expertise required in the synthesis of enantio-selective drug delivery 
vehicles. To the best of our knowledge, the simplicity of this inversion is unprecedented. 
  
Figure 3.10. Release of ibuprofen at 37 °C. A) Two concentrations: 102 µM (maximum 
solubility) and 1020 µM (10x maximum solubility). Enantio-preference is retained well 
above water solubility of ibuprofen. B) Enantio-inversion of release from hydrogels 




NaDC/TRIS hydrogels were investigated for use as solute delivery vehicles. 
Temperature, hydrogel formulation, solute loading concentration, solute solubility, time, 
and application of shear force were all found to be factors in the amount of solute 
released. Increased temperature was found to reduce differences between release from 
sheared and non-sheared hydrogels. Hydrogel formulation was found to affect release 
differently at different temperatures and for different solute sizes. Solute release was 
found to be linearly proportional to concentration of solute loaded, ideal for calculating 
dosages. Sodium deoxycholate/TRIS-based hydrogels were also found to be useful as 
enantio-preferential release systems. With the addition of γ-cyclodextrin to the hydrogel 
network, I was able to invert enantio-preference: R-ibuprofen was preferentially 
released from a native gel, while S-ibuprofen was preferentially released from a 
modified gel. Ergo, the presented hydrogel system has exceptional potential for a wide 
variety of applications in which one enantiomer is desired over the other. When the 
inherent benefits of hydrogels are considered with the additional benefits of the 
presented system, these NaDC/TRIS hydrogels are a significant addition to the current 
library of solute delivery systems.  
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CHAPTER 4.  
NOVEL FLUORESCENCE-BASED RATIOMETRIC NANOSENSOR FOR 
SELECTIVE IMAGNG OF CANCER CELLS 
 
4.1. Introduction 
Extracellular and intracellular pH sensing are important tasks due to fluctuation of 
pH with conditions such as cancer and bacterial infections. Healthy extracellular pH is 
generally between 5.5 and 7.4. However, extracellular pH in healthy individuals can be 
lowered due to renal failure, acidosis, COPD, and many other conditions.1,2 Intracellular 
pH is tightly regulated by both normal and cancerous cells with typical values of 7.0-
7.4.3 Therefore, an extracellular pH sensor would be an effective diagnostic tool for pH-
affecting conditions. Such pH sensors are also of great importance to agricultural,4 
environmental,5 biological,6 and food manufacturing applications. For instance, the dairy 
industry requires pH sensing for several processes such as to check freshness of milk, 
bacterial conversion of lactose to lactic acid in yogurt, cheese production, and so on.7 
The importance of pH sensing has led to development of many types of sensors such 
as potentiometric sensors,8 electrolyte–insulator–semiconductor sensors,9 and 
fluorescent sensors. Fluorescent pH sensors are of particular interest owing to high 
sensitivity, selectivity, and speed inherent to  fluorescence measurements.10,11 
Nanomaterials can be used to enhance many such pH sensors by facilitating 
manipulation of solubility, fluorescence intensity, and combination of multiple beneficial 
components.12 Furthermore, nanoscale pH sensors are important for intracellular pH 
sensing because they can be used with minimal invasion and can be synthesized in a 
size-controlled process for optimum cellular uptake.13   
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Common designs of nanoscale fluorescent pH sensors include incorporation of 
fluorescent moieties into different nanoparticle matrices made up of polymer,14,15 
silica,16,17 etc. Microemulsion approach has also been applied for formation of pH-
sensitive fluorescent nanoparticles.18 Regardless of the method used to synthesize 
nanoparticles, several properties are required from an ideal nanoparticle-based pH 
sensor depending on the application. As an example, for cellular pH sensors, one of the 
important properties is that the range of pH sensing ability should encompass pH values 
relevant to the biological systems of interest.19 Additionally, sensing should not be 
inhibited by components within the cell, such as calcium and sodium ions.20 Typical 
fluorescence-based pH sensing techniques are impacted by variables such as source 
intensity, photobleaching, and path length of the measurement. These variables require 
calibration of sensing systems for accurate measurements.21 The need for calibration is 
an especially large deficiency for cellular studies due to variation in path length between 
different parts of the cell and between different cells.22  
Fluorophores with two emission peaks can be used to overcome calibration 
needs. Ratiometric responses (i.e. the emission intensity ratio between the two peaks) 
can be achieved using a single fluorophore with varied acidic and basic emission,23 two 
fluorophores that exhibit pH-dependent Fӧrster resonance energy transfer (FRET),24 or 
one fluorophore with pH-dependent emission and one fluorophore with pH-independent 
emission.25 Ratiometric measurements provide an intrinsic calibration that is inert to 
typical sensitivities of cellular fluorescent measurements. 
 Despite many and varied needs for pH sensors, there is still significant need for 
inexpensive pH sensors with straightforward synthesis.26 A group of uniform materials 
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based on organic salts (GUMBOS) are solid phase ionic materials renowned for their 
tunability and broad applicability, possibly including as pH sensors.27 Potential 
GUMBOS applications vary from photosensitizers in solar cells,28 use in OLEDs,29 
sensing applications,30,31 cancer treatment,32 and beyond. In this study, I demonstrate a 
three-component, nanoscale, fluorescent GUMBOS as a pH sensor probe derived from 
fluorescein (FL), rhodamine B (RhB), and tetradecyltrihexyl phosphonium ions (P66614), 
called [P66614][RhB][FL]. Cationic P66614 was chosen for its significantly hydrophobic 
quality that is necessary for nanoparticle formation in aqueous media. Anionic 
fluorescein and cationic rhodamine B were selected for their satisfactory spectral 
overlap that is essential for FRET, where fluorescein serves as donor and rhodamine B 
works as acceptor. Intermolecular distance between donor and acceptor is critical and 
should be less than 10 nm for efficient FRET.33 By incorporating these ions into a 
GUMBOS, the intermolecular distance between donor and acceptor is sufficiently 
reduced compared to mixing of two separately prepared solutions of fluorescein and 
rhodamine B. Different FRET efficiencies will result in different ratios of fluorescence 
emission peaks. Hence, ratiometric analysis can easily be performed on fluorescence 
emission peaks of [P66614][RhB][FL]. Nanoparticles of [P66614][RhB][FL] yielded an 
intrinsically calibrated fluorescence method for pH distinction between pH values of 4 
and 7. This three-component nanoGUMBOS was also found to be preferentially taken 
up by cancer cells, providing a fast visual detection method. NanoGUMBOS of 
[P66614][RhB][FL] are herein characterized and analyzed for use as pH-sensing and 
cancer imaging agents.  
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4.2. Materials and methods 
4.2.1. Materials 
Disodium fluorescein (≥97.5%), rhodamine B (≥95%), and tetradecyltrihexyl 
phosphonium chloride ([P66614][Cl]) (≥95%) were purchased from Sigma Aldrich and 
used as received. Dichloromethane (DCM) (≥99.9%) was purchased from Fisher 
Scientific and used as received. Water used in all experiments is triply deionized (18 
MΩ cm) and obtained from an Aries Filterworks high-purity water system. 
4.2.2. Synthesis of GUMBOS 
[P66614][RhB][FL] GUMBOS was synthesized using a stepwise reaction. Initially, 
[P66614][FL] GUMBOS was synthesized based on procedure described elsewhere.34 
Thereafter, the required [P66614][RhB][FL] GUMBOS was synthesized by ion exchange. 
The comprehensive reaction scheme can be found in Figure 4.1. In brief, disodium 
fluorescein was dissolved in pH 5.5 citrate buffer resulting in a mono-anionic species. In 
a 1:1.1 molar ratio (P66614:FL), [P66614][Cl] in dichloromethane (DCM) was added to 
aqueous fluorescein and allowed to stir 48 hours. After stirring, fluorescein could be 
seen prominently in the DCM layer. Excess fluorescein remained unreacted as 
evidenced by slight coloration of the water layer. This transfer suggested that 
fluorescein ionically associated with the phosphonium cation to form a water insoluble 
salt. The DCM layer was washed several times with water to remove excess unreacted 
fluorescein and NaCl byproduct. Aqueous rhodamine B was added in a 1.1:1 molar ratio 
(rhodamine B:[FL][P66614]) and left to stir 48 hours until rhodamine B was no longer 




Figure 4.1. Reaction scheme of  [P66614][RhB][FL] GUMBOS synthesis. ESI-MS peaks 
with m/z 331, 443, and 521 confirmed the presence of the three expected components 
in the final product. 
was removed. The DCM layer was washed with water several times to remove any 
unreacted rhodamine B and byproduct. The final product was obtained by removing 
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DCM through rotary evaporation. The sample was subsequently lyophilized to remove 
any water. 
Synthesis of [P66614][RhB][FL] GUMBOS was confirmed by Bruker 400 Nanobay 
NMR (Figure 4.2). Thermal gravimetric analysis was performed using a TA Instruments 
TGA 2950 (TA Instruments, New Castle, DE). 
4.2.3. Synthesis of nanoGUMBOS 
NanoGUMBOS were synthesized using a reprecipitation method in which 60 µL 
of 1 mM ethanolic GUMBOS was added to 3 mL water under sonication. For pH 
studies, nanoGUMBOS synthesized in water were injected into buffer of desired pH for 
a final concentration of 2 µM. Size and morphology of resulting nanoGUMBOS were 
characterized using a JEOL1011CX transmission electron microscope (JEOL USA, Inc., 
Munich, Germany). 
4.2.4. Spectroscopic studies of GUMBOS and nanoGUMBOS 
Absorbance studies were performed using a Shimadzu UV-3101PC UV-vis-NIR 
scanning spectrometer (Shimadzu, Columbia, MD). Quartz cuvettes (Starna cells) with 
a 0.4 cm path length were used for all spectral analyses. For acquiring absorbance 
spectra, an identical cell was filled with water or buffer, as the case may be, and used 
as reference. Fluorescent emission spectra were obtained using a Fluorolog-3 
spectrofluorimeter (model FL3-22TAU3; HORIBA Scientific, Edison, NJ) with 1 nm slit 
widths using right angle geometry.  
4.2.5. Cell culture 
Normal human breast fibroblast (Hs578BST, ATCC no. HTB-125) and human 





Figure 4.2. NMR comparison (expanded spectra) of [P66614][RhB][FL] GUMBOS with 
parent compounds (DMSOd6 as solvent). 
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Type Culture Collection (ATCC, Manassas, VA) and grown to 90% confluence as per 
the instructions. 
4.2.6. Fluorescence microscopy 
Five thousand cells of each cell line (normal breast and breast carcinoma) were 
plated in 3 mL of cell media on a 25 mm glass bottom petri dish (10 mm micro cell; 
Ashland, MA, USA) and incubated for 24 h. Following incubation, the cell culture media 
was replaced by cell media containing suspended 25 nM [P66614][RhB][FL] 
nanoGUMBOS and incubated for an additional 30 min. Fluorescence microscopy 
images were captured with a 40X dipping objective lens with a TRITC fluorescence filter 
and DIC polarization. All fluorescence images were captured with a 5000 s exposure 
time for consistency. 
4.3. Results and discussion 
4.3.1. Spectroscopic characterization of synthesized GUMBOS 
In addition to NMR confirmation and supporting ESI (Figure 4.1 and 4.2), 
GUMBOS synthesis can be supported by comparing UV-vis absorbance and 
fluorescence spectra of parent dyes and GUMBOS. The absorbance spectrum of 
[P66614][RhB][FL] GUMBOS retained all spectral features of parent dyes fluorescein and 
rhodamine B (Figure 4.3). However, the absorbance of FL at 505 nm is significantly 
reduced in [P66614][RhB][FL] compared to native FL and shoulders in the absorption 
spectrum of [P66614][RhB][FL] at approximately 430 and 450 nm were present. 
Absorbance of [P66614][RhB][FL] between 400 and 520 nm corresponds to the known 
absorbance spectrum of mixed protolytic forms of FL (viz. cationic, neutral, 
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monoanionic, and dianionic).35 Reduced absorbance at 505 nm further supports that 
multiple FL species (i.e. protolytic forms) exist within the three-component GUMBOS. 
Absorbance of parent dye RhB was not significantly impacted by incorporation into 
[P66614][RhB][FL]. Stability of RhB absorbance in [P66614][RhB][FL] indicates that 
GUMBOS formation is not likely to inhibit FRET acceptance. 
 
Figure 4.3. Normalized UV-vis absorbance spectra of ethanolic solutions: 10 µM of 
parent dye rhodamine B, 10 µM of the parent dye fluorescein, a mixture containing 10 
µM each of rhodamine B and fluorescein, and 10 µM [P66614][RhB][FL] GUMBOS. 
 Fluorescence spectroscopy was used to further verify synthesis of 
[P66614][RhB][FL] GUMBOS (Figure 4.4). Fluorescence emission of individual parent 
dyes was somewhat affected by the presence of the other fluorophore in solution. That 
is, a solution with 10 µM each fluorescein and rhodamine B showed fluorescence 
emission in which the fluorescein peak intensity was slightly quenched while RhB 
emission was enhanced, indicating a slight occurrence of FRET. Fluorescence emission 




























µM each. When the two dyes were incorporated into a GUMBOS with P66614, the 
fluorescence emission peak corresponding to fluorescein was reduced significantly, 
much more so than in free solution. This reduction in emission is likely due, in part, to 
reduced absorbance of [P66614][RhB][FL] GUMBOS at the excitation wavelength. 
Furthermore, emission of [P66614][RhB][FL] at 565 (band corresponding to rhodamine B) 
was more intense than at 520 nm (band corresponding to fluorescein). The change in 
intensity ratios suggested that formation of GUMBOS reduced the distance between 
fluorescein and rhodamine B sufficiently for significant FRET to occur.  
 
Figure 4.4. Normalized fluorescence spectra of 10 uM ethanolic solutions of fluorescein, 
rhodamine B, fluorescein and rhodamine B, and [P66614][RhB][FL] GUMBOS. λex = 495 
nm. 
4.3.2. Spectral overlap integral of fluorescein and rhodamine B 
In addition to limited spatial distance, another condition for FRET to occur is 























spectrum of acceptor. A high spectral overlap indicates the possibility of high FRET 
efficiency. Calculation of spectral overlap integral was performed using the following 
equation: 
                             
where ε is the molar extinction coefficient of acceptor species (cm-1M-1), (λ) is the 
normalized emission intensity of donor, and λ is the wavelength. Fluorescein (donor) 
and rhodamine B (acceptor) were chosen because they have significant spectral 
overlap, calculated to be J(λ) = 4.88 1015 M-1cm-1nm4 under studied experimental 
conditions (Figure 4.5).  
 
Figure 4.5. Spectral overlap of normalized fluorescein emission and rhodamine B 
absorbance. Shaded area indicates spectral overlap (J(λ)). 
4.3.3. Energy transfer efficiency of [RhB][FL][P66614] GUMBOS 
Energy transfer efficiency (E) was calculated using the following equation: 
%            
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where Fda is the fluorescence intensity of donor in presence of acceptor and Fd is the 
fluorescence intensity of donor in absence of acceptor. E quantifies the percent of 
energy emitted by donor that is subsequently absorbed by acceptor. A higher value of E 
indicates a more efficient FRET pair. For calculation of E relevant to this study, 
ethanolic fluorescein was used for Fd determination, and [P66614][RhB][FL] GUMBOS 
was used for Fda determination. Energy transfer efficiency was calculated to be 66% in 
[P66614][RhB][FL] GUMBOS, further demonstrating occurrence of FRET. 
4.3.4. Spectroscopic analysis of nanoGUMBOS 
Spectroscopic analyses were performed on [P66614][RhB][FL] nanoparticles 
suspended in pure water to understand the formation of nanoGUMBOS and for later 
comparison with pH-adjusted water. I found that in pure water, the nano[P66614][RhB][FL] 
absorbance spectrum (Figure 4.6) retained all features of parent dyes. However, the 
absorbance value was significantly decreased in nanoGUMBOS compared to parent 
dyes. Decreased and broadened absorbance is not unexpected with nanoparticle 
formation and can be attributed to aggregation, absence of motional narrowing, and 
asymmetrical molecular arrangement (lattice disorder).28,36,37,38 
Fluorescence emission spectra of parent dyes and nanoGUMBOS were obtained 
with an excitation wavelength of 495 nm, i.e. maximum absorbance of FL, in order for 
FRET to occur (Figure 4.7). As expected, RhB had a significantly lower fluorescence 
emission than FL due to low absorbance of RhB at 495 nm. When an aqueous solution 
containing FL and RhB was excited at this wavelength, FL emission was quenched 
approximately 9% (from 761,000 to 696,000 a.u.). Emission intensity corresponding to 
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RhB emission maximum (λ = 575 nm) is apparently enhanced from 25,500 to 91,100 
a.u. this emission was purely the sum of molecular fluorescein and rhodamine B  
 
Figure 4.6. Normalized absorbance spectra of aqueous parent dyes fluorescein and 
rhodamine B in separate solutions, a solution containing both parent dyes, and 
[P66614][RhB][FL] nanoGUMBOS in water. 
emissions. Lack of enhancement in rhodamine B emission suggested that an aqueous 
solution containing molecular fluorescein and rhodamine B did not undergo significant 
FRET. It can be discerned that FL and RhB were oriented in aqueous solution in a way 
that inhibited FRET. NanoGUMBOS suspended in water and excited at 495 nm 
exhibited significantly decreased fluorescein emission. Fluorescein incorporated into 
nanoGUMBOS had emission quenched to 78% of fluorescein emission in free solution. 
Rhodamine B emission was enhanced over 14 fold as a component of nanoGUMBOS 
(from 25,400 a.u. in free solution to 359,000 a.u. in nanoGUMBOS). Fluorescence of 





























rhodamine B emission at 570 nm that was not seen in a solution with a mixture of 
fluorescein and rhodamine B when excited at 495 nm. Spectral properties thus indicated 
 
Figure 4.7. Normalized fluorescence emission spectra of aqueous parent dyes 
fluorescein and rhodamine B in separate solutions, a solution containing both parent 
dyes, and [P66614][RhB][FL] nanoparticles in water. λex = 495 nm. 
that in aqueous solutions, nanoparticles of [P66614][RhB][FL] underwent FRET. The 
occurrence of FRET suggested that this three-component GUMBOS may be suitable as 
a FRET-based sensor. 
4.3.5. Effect of pH on spectral properties of [P66614][RhB][FL] nanoGUMBOS 
Absorbance spectra of [P66614][RhB][FL] nanoparticles at a wide range of pH 
values yielded information about the form of fluorescein present at each pH (Figure 
4.8A). The absorbance band at 550 nm corresponds to the rhodamine B component of 































This pattern is comparable to known absorbance properties of molecular rhodamine B.39 
Therefore, any pH-dependent changes in rhodamine B emission can be attributed to 
association of rhodamine B with fluorescein and P66614. In practical applications of 
fluorescence-based measurements, a single excitation wavelength with dual emission 
wavelengths is typically more feasible than a dual excitation wavelength.40 For this 
reason, I excited [P66614][RhB][FL] nanoparticles at a single wavelength, viz. 495 nm, 
and examined resulting emission at seven pH values (Figure 4.8B). 
At pH 2, [P66614][RhB][FL] nanoparticles yielded an absorbance band at 437 nm. 
This band was indicative of cationic fluorescein.35 Interestingly, [P66614][RhB][FL] 
nanoparticles at pH 2 did not exhibit any other absorbance bands attributed to 
fluorescein. This spectrum suggested that at pH 2, cationic fluorescein was the primary 
species in [P66614][RhB][FL] nanoGUMBOS. The fluorescence emission band of 
[P66614][RhB][FL] nanoparticles at pH 2 was significantly lower than at other pH values. 
This low emission was largely due to low absorbance of [P66614][RhB][FL] at the selected 
excitation wavelength of 495 nm (characteristic of cationic fluorescein). The rhodamine 
B emission band in nano[P66614][RhB][FL] was significantly higher than in the parent dye 
alone indicating occurrence of FRET. The fluorescein emission band of 
nano[P66614][RhB][FL] in pH 2 buffer was approximately 15 nm red-shifted from that of 
the parent compound. This shift was most likely due to J-aggregation (i.e. head-to-tail 
stacking).41 
 Absorbance of [P66614][RhB][FL] at pH 4 featured very little indication of 
fluorescein present. Molecular fluorescein with neutral charge is known to exhibit very 




Figure 4.8. Spectral properties of [P66614][RhB][FL] nanoGUMBOS in buffers of seven 


























































There was a broad absorbance band of very low intensity (between 0.05 and 0.1 units) 
from 460-490 nm that indicated slight absorbance of monoanionic fluorescein. 
Molecular fluorescein has a pKa of 4.31 for the transition from neutral to monoanionic 
form. Because pH 4 is close to the pKa of fluorescein it was not unexpected to see 
spectral contributions from both the neutral and monoanionic species. A previous study 
by Das et al. also demonstrated stable nanomaterials derived from fluorescein-based 
ionic materials with multiple protolytic forms of fluorescein present.34 Emission of 
nano[P66614][RhB][FL] at pH 4 was comparable to that at pH 2. The fluorescein band 
was again low intensity and red-shifted compared to the parent dye and to other pH 
values. Low emission was again due to low absorbance as described earlier. 
 The [P66614][RhB][FL] nanoparticles absorbed broadly at pH 5. Absorbance was 
relatively low (viz. between 0.1 and 0.2) and broad across the known absorbance 
wavelengths of fluorescein. This spectrum and known fluorescein pKa values suggested 
that at pH 5, monoanionic form of fluorescein was present in nano[P66614][RhB][FL].43 
Fluorescence emission at fluorescein band (515 nm) increased from that of more acidic 
pH values due to increased absorbance of the monoanionic form and correspondingly 
higher molar extinction coefficient at the chosen excitation wavelength.42 Emission at 
rhodamine B band (575 nm) was also increased from the more acidic environment of 
pH 2. This emission is not expected to change with pH when excited at 495 nm. 
Therefore, this increase can be attributed to increased FRET resulting from more 
intense fluorescein emission. Emission at pH 5 was not significantly shifted from parent 
compound emission indicating that J-aggregates were not prevalent at this pH. It has 
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previously been demonstrated that the protolytic form of fluorescein participates in 
directing prevalence and type of aggregation (i.e. J or H). 34 
 The absorbance spectrum of nano[P66614][RhB][FL] at pH 6 was similar in 
broadness and intensity to the spectrum at pH 5 with two exceptions: At pH 6 there was 
a slight increase (0.02 units) in the absorbance band at 485 nm and a significant 
decrease in apparent shouldering from rhodamine B around 510 nm. Fluorescein has a 
pKa of 6.45 between mono- and di-anionic forms. Proximity of pH 6 to this pKa resulted 
in multiple fluorescein species as seen in the absorbance spectrum. Emission of 
nano[P66614][RhB][FL] at pH 6 was significantly higher than at pH 5 for the fluorescein 
band despite comparable absorbance at the excitation wavelength. Dianionic 
fluorescein has significantly more intense fluorescence than monoanionic fluorescein.43 
Therefore, increased fluorescence intensity was likely due in part to the presence of 
dianionic fluorescein in nano[P66614][RhB][FL] at pH 6. The emission band 
corresponding to rhodamine B was only slightly more intense than that of pH 5. This 
contrast in spectra strongly suggested that FRET decreased at pH 6. TEM images 
revealed that at pH 6, nano[P66614][RhB][FL] had slight solubility. Expansion of 
nanoparticles at this pH increased distance between fluorescein and rhodamine B 
components to reduce the efficiency of FRET. Decreased FRET would also have 
contributed to a more intense (less quenched) emission at the fluorescein band. 
 Spectral properties of nano[P66614][RhB][FL] did not differ significantly between 
pH values of 7 and 10. Between these pH values, molecular fluorescein remains 
dianionic. The intense absorbance band at 495 nm indicated that dianionic fluorescein 
was the primary species present in nanoGUMBOS at these pH values. As predicted, 
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intense absorbance at the excitation wavelength resulted in significantly more intense 
fluorescence emission at 510 nm than seen in other pH values. The fluorescence band 
corresponding to rhodamine B was almost twice the intensity of the band in more acidic 
environments. However, intensity of rhodamine band was only 60% of the fluorescein 
band. Varied absorbance of fluorescein within [P66614][RhB][FL] nanoparticles at 
different pH values and apparent differences in fluorescence intensities suggested that 
this GUMBOS can be used for pH-dependent emission using a single excitation 
wavelength.  
 Ratiometric calculations can be used for intrinsically calibrated determination of 
pH as previously discussed.44,45 The ratio of intensities was calculated between 512 nm 
and 575 nm. As depicted in Figure 4.9, linearity of ratiometric pH response of 
[P66614][RhB][FL] nanoparticles was between approximate pH values of 5 and 7. This pH  
 
Figure 4.9. Ratio of fluorescence emission intensities at 512 nm and 575 nm. These 
























range aligns well with the desire for cellular pH determination. Ratiometric analysis 
cannot be used with this material to differentiate pH values between 2 and 4, or 
between 7 and 10. However, this material can be used for qualitative analysis of pH 
values lower or higher than the linear range. For example, a ratio of 0.22 could indicate 
acidity too high for normal cells, but not quantify pH of the cells. 
4.3.6. Size analysis of [P66614][RhB][FL] nanoGUMBOS 
Nanoparticles derived from [P66614][RhB][FL] were synthesized in pure water 
using a reprecipitation method. As can be seen from Figure 4.10A, uniform size 
distribution of nanoparticles with average size 4.4 ± 0.7 nm was observed from TEM 
micrograph analysis. When these particles were injected into buffer solutions at various 
pH values, size distribution of nanoparticles was found to differ between different 
environmental acidities, especially at extreme pH values (viz. 2 and 10). It has 
previously been shown that both the protolytic form of fluorescein34 (where applicable) 
and several types of interactions (covalent and noncovalent)46  impact molecular 
arrangement of nanoparticles and can impart pH-induced size changes. At pH 2, 
molecular fluorescein exists in in the cationic form.42 [P66614][RhB][FL] nanoparticles 
injected into pH 2 buffer coalesce into significantly larger particles of 69.7 ± 8.1 nm 
(Figure 4.10B). Relatively large nanoparticles suggested that presence of cationic 
fluorescein (as seen in absorbance spectrum, Figure 4.8A) exhibited sufficient repulsion 
with P66614 cations to increase particle size. Such changes in size due to intraparticle 
interactions with pH were previously described in detail.34 Despite this significant size 
and repulsion increase, particles are uniformly sized with spherical shape. 
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Between pH 4 and 8, [P66614][RhB][FL] nanoparticle size was not significantly 
altered upon injection into buffer solutions (relative to suspension in water). 
Nanoparticles at pH 4 were found to be 4.3 ± 0.7 nm (Figure 4.10C). Molecular 
fluorescein would be neutral at this pH value. The presence of neutral fluorescein 
species is supported by the absorbance spectrum (Figure 4.8A). Interestingly, no 
significant size difference was observed at pH 4 compared to pure water. Neutral 
fluorescein would not be expected to have significant intraparticle repulsion effects with 
cationic components. Therefore, size preservation further supported the theory that 
nanoparticle size is partially driven by the protolytic form of fluorescein and the resulting 
intraparticle interactions.  
Between pH values of 5 and 6 molecular fluorescein would be 
monodeprotonated. Nanoparticles of [P66614][RhB][FL] were found to aggregate into a 
network of material at these pH values (Figure 4.10D, E). Within many of these 
networks of material, particles of approximately 4-5 nm were retained. However, 
boundaries of nanomaterials were indistinct. At these pH values, [P66614][RhB][FL] 
appeared to be slightly soluble, thereby decreasing nanoparticle stability. A buffer of pH 
7 resulted in distinct particles embedded in a network of material (Figure 4.10F). 
However, at pH 7 particles could be more clearly distinguished from surrounding 
network than at pH 5 and 6. Average particle size found in the network of pH 7 were 
found to be 4.2 ± 0.5 nm, statistically equivalent in size to particles in pure water. A pH 
value of 8 also resulted in particles of similar size and shape (Figure 4.10G) to those 
formed in pure water (viz. 3.8 ± 0.6 nm). Molecular fluorescein is dianionic at both pH 7 
and 8. The two negative charges strongly interacted with cationic rhodamine B and 
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P66614 to retain GUMBOS and nanoparticle association at these pH values. Interestingly, 
this size stability was not seen at pH 10 (Figure 4.10H). Basic pH 10 resulted in 
coalescence of [P66614][RhB][FL] nanoparticles into larger particles of 71.0 ± 11.0 nm. 
The substantial increase in hydroxide ions between a pH 8 solution and a pH 10 
solution resulted in a more favorable environment for combination of 4 nm 
[P66614][RhB][FL] particles into larger diameter particles. 
 
Figure 4.10. TEM micrographs of [P66614][RhB][FL] nanoGUMBOS in A) pure water, B) 
pH 2, C) pH 4, D) pH 5, E) pH 6, F) pH 7, G) pH 8, H) pH 10. 
4.3.7. [P66614][RhB][FL] nanoGUMBOS for fluorescence microscopy imaging of 
cancer cells 
The significant difference between fluorescent peak ratios at pH 5 and pH 7 (0.70 
and 2.2, respectively) implied that [P66614][RhB][FL] nanoparticles could be useful for 
cancer imaging applications. Fluorescence microscopy filters can be selected to pass 
fluorescein emission and rhodamine B emission separately. In this case, measured 
intensities (from each filter) can be used to ratiometrically determine pH in situ. This 
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analysis is strongly beneficial, not only in cancer detection, but for many human 
conditions involved in pH change (e.g. acidosis).  
Two cell lines, normal human breast cells and cancerous human breast cells, 
were incubated with 25 nM [P66614][RhB][FL] nanoparticles. Control studies were done 
with equivalent concentrations of parent dyes (Figure 4.11 A-B). Fluorescence 
microscopy images were obtained using a TRITC filter and a DIC polarizing filter. A 
clear visual distinction could be made between normal and cancer cells incubated with 
nano[P66614][RhB][FL] (Figure 4.11C). Cancer cells exhibited intense fluorescence 
throughout the entirety of the cell, except for the nucleus. Normal cells exhibited 
significantly less distribution of fluorescence than cancer cells, where only scattered 
fluorescence can be seen. Studies of parent dye fluorescein showed that incubation in 
normal and cancer cells both resulted in fluorescence throughout the cell. Studies of 
parent dye rhodamine B showed that incubation in normal and cancer cells both 
resulted in localized fluorescence in the nucleus. Comparison of [P66614][RhB][FL] 
nanoGUMBOS to parent dyes revealed that formation of nanoGUMBOS serviceably 
causes differentiation of cellular uptake between cancerous and normal cells and, 
effectually, observed fluorescence. This substantial visual difference indicated that 
[P66614][RhB][FL] nanoGUMBOS can be useful in imaging of cancer cells, especially due 
to ease and speed required for visual diagnostic analyses.  
4.3.8. Photostability and thermostability of [P66614][RhB][FL] 
Photostability is an important characteristic of dyes developed for biomedical 
imaging.47,48 High photostability in a material results in longer shelf-life and more 
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reproducible measurements over time. As depicted in Figure 4.12A, an exceptional 
photostability of [P66614][RhB][FL] GUMBOS was observed with an increase of 170% 
over the first 11000 s. From 11000 to 36000 s, photostability was nearly constant at  
 
Figure 4.11. Fluorescence microscopy images of 25 nM parent dyes and sensor in 
normal and cancerous breast cells. All images have TRITC and DIC filters applied for 
visualization of cells. A) FL, B) RhB, and C) [P66614][RhB][FL] nanoGUMBOS. 
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170%. Fluorescein was reduced to 74%, and rhodamine B remained at 98% over the 
same time period (Figure 4.12B). However, the lack of photobleaching in case of RhB is 
presumably due to insignificant absorbance at the chosen excitation wavelength. 
Increased photostability was also observed in previous studies where Lu et al. ascribed 
this increase in photostability to laser-induced J-aggregation.34,49 This increase in 
fluorescence emission with light exposure is a strong advantage for practical utility of 
[P66614][RhB][FL], especially in the case of fluorescence imaging. Thermal stability is 
another important characteristic of materials exposed to lasers. Bulk [P66614][RhB][FL] 







Figure 4.12. Photostability A) fluorescein and rhodamine B (λex=495 nm). B) 




































In this work, I have shown synthesis of [P66614][RhB][FL], a three-component 
GUMBOS derived from fluorescein, rhodamine B, and tetradecyltrihexyl phosphonium. 
NanoGUMBOS were found to have consistent size of approximately 4 nm with changes 
in pH. However, in the case of very acidic or very basic conditions (i.e. pH 2 and 10 
respectively), particles were significantly larger (approximately 70 nm). 
Nano[P66614][RhB][FL] exhibited pH-dependent spectral properties. Absorbance spectra 
of the nanoGUMBOS indicated that the protolytic form of fluorescein within the 
nanoparticle corresponded to that of fluorescein in solution. Fluorescence emission of 
nano[P66614][RhB][FL] exhibited two bands corresponding to fluorescein and rhodamine 
B. Both bands increased with increasing pH due to enhanced absorbance in more 
anionic forms of fluorescein and increased FRET, with the exception of pH 6. FRET was 
slightly decreased at this pH due to slight solubility. Intramolecular FRET yielded a 
fluorescent peak ratio that varied significantly between pH 5 and pH 7, an essential 
range for cellular pH sensing. Cancer cells incubated with [P66614][RhB][FL] 
nanoparticles were found to have a greater selective distribution of fluorescence over 
normal cells incubated with equivalent experimental conditions. Such differentiation 
could not be made with equivalently analyzed parent compounds. This visual difference 
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Chapter 5.  
Conclusions and Future Work 
5.1. Conclusions  
In this dissertation, I have outlined the development and exploration of sodium 
deoxycholate(NaDC)/TRIS-based hydrogels and a fluorescein/rhodamine B-based 
GUMBOS for biomedical applications. In the first chapter, I provide a broad outline of 
hydrogels including classification and properties and a brief outline of GUMBOS 
applications. Stimuli-responsive hydrogels and drug delivery applications are discussed, 
highlighting the idea that each application of hydrogels requires a distinct set of 
properties: A hydrogel perfectly suited for one application may be useless in another. To 
this point, I discuss a tunable hydrogel system and its potential for applications. 
In the second chapter, NaDC/TRIS hydrogels were modified through changes in 
pH and [TRIS] of the immobilized solution. It was found that these modifications 
significantly affected the properties of this system. For example, by increasing [TRIS] 
the number of hydrogen bonding sites is increased. This resulted in increased 
crystallinity, mechanical strength, and sol-gel temperature. Structural rigidity of the 
hydrogel network was also found to be affected by changes in pH. Fewer hydrogen 
bonding sites are present when above the pKa of NaDC, resulting in lower mechanical 
strength. Near-IR dyes were used to form GUMBOS. The tunability of these hydrogel 
materials allowed for tunable synthesis of nanoparticles from these GUMBOS. 
Especially when coupled with the inherent biocompatibility of hydrogels, this could be 
particularly useful in imaging applications. Characterization in this chapter can be used 
to determine the suitability of these materials to a desired application. 
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In the third chapter of this dissertation, I thoroughly examined the application of 
solute release. It was found that at room temperature, there is a substantial difference in 
the amount of solute released from gels that had and had not been sheared. At the 
physiologically relevant temperature of 37 °C, these significant differences were 
reduced. This indicates that the mode of delivery must be considered when calculating 
the dosage of a gel. Hydrogel formulation, loaded solute concentration, solute solubility, 
and time were also found to impact solute release. Drug release was found to increase 
linearly with the amount of drug loading, facilitating dosing calculations. NaDC/TRIS-
based hydrogels were found to have inherent enantio-preferential release. One 
enantiomer of model chiral molecules was found to be preferentially released from the 
hydrogels when loaded in equal amounts in sister samples. This is extremely beneficial 
for drug delivery applications in which the racemic mixture is commercially available but 
one enantiomer has unfavorable effects in the body. Through addition of cyclodextrin, 
enantiopreferential inversion was possible. This is exceptionally important in cases 
where the less desirable enantiomer is released by the native gel. In conjunction with 
the inherent biocompatibility of hydrogels and the tunability of this system, native 
enantioselectivity provides great potential for the use of these hydrogels in drug delivery 
applications. 
In the fourth chapter of this dissertation I explored synthesis, characterization, 
and potential applications of a three-component nanoGUMBOS, nano[P66614][RhB][FL]. 
NanoGUMBOS were uniform in size between pH values of 4 and 8 after facile 
synthesis. Fluorescein and rhodamine B components of the nanoGUMBOS contributed 
to pH-dependent spectral properties. Two fluorescence emission bands were observed 
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and increased in intensity with increasing pH due to the protolytic forms of fluorescein 
and rhodamine B components. Intramolecular FRET resulted in ratiometric differences 
between the emission bands at varied pH levels. Significant ratiometric variation was 
found between pH values of 5 and 7, a range highly relevant for cellular pH. In vitro 
fluorescence microscopy revealed that cancer cells incubated with 
nano[P66614][RhB][FL] had significantly greater fluorescence distribution than normal 
cells incubated equivalently. Such obvious visual differentiation indicates pronounced 
potential for use of these nanoGUMBOS in visual cancer diagnosis. 
5.2. Future work 
Thus far, the potential of these hydrogel materials for use in drug delivery 
applications has been discussed at length. However, several more studies must be 
performed before their clinical use. Toxicity studies will be critical to ensure successful 
use. The components of the hydrogels are deoxycholate (a bile acid), TRIS (a medically 
used buffer), and water. Thus, toxicity is expected to be very low. One potential concern 
is the surfactant properties of deoxycholate. However, it is anticipated that the assembly 
of a gel network will prevent surfactant action. Biodegradation studies will also be 
required before clinical application of NaDC/TRIS hydrogels. Particularly due to the 
absence of polymers and the natural presence of deoxycholate in the body, I anticipate 
that biodegradation will occur acceptably. Finally, in vivo studies will need to be 
performed. Drug release profiles may be affected by substituents in the body and 
therefore need to be analyzed thoroughly before being used pharmaceutically. 
 Several modes of delivery were discussed in this work. Future work could include 
exploration of nanogels as delivery systems. As the name suggests, nanogels are 
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crosslinked (physically in this case) networks on the nanoscale. They typically retain the 
beneficial properties of macroscale hydrogels with the additional benefits of 
bioavailability. For example, nanogels can be used to transport drugs to difficult places 
such as across the blood brain barrier. There are currently many methods for synthesis 
of such materials, so it is expected that a suitable method could be found to further 
enhance these tunable materials. 
 Drug delivery was a focus of this dissertation, but it is important to note that 
hydrogels can be applied in a wide variety of fields. Especially due to the tunability of 
this system, several applications can be explored in the future. Hydrogels can be used 
in sensing applications, for example. I have shown that these materials are sensitive to 
their environment, can be loaded with many different solutes of different sizes and 
properties, and are highly tunable in mechanical strength, crystallinity, and other 
properties. This is strong evidence that they may be used effectively in sensing 
applications. The biocompatibility and ability to load solutes easily also suggest that 
they may be useful in imaging applications. Whether in drug delivery, sensing, or 
imaging, future work on NaDC/TRIS hydrogels can involve the choosing of a specific 
application. When a desired application is specifically defined, the hydrogels can be 
tuned to fit the requirements of that particular application.  
 Due to the high potential for nano[P66614][RhB][FL] to be used in cancer 
diagnoses, future work should be aimed at further understanding the uptake properties 
and development of this approach for clinical applications. Primary efforts should be 
towards analysis of pH within the cells and in media surrounding the cells. Such 
analysis could significantly further the diagnostic ability of this material. Uptake 
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mechanism and cytotoxicity studies may reveal further uses of nano[P66614][RhB][FL]. 
Synthesis of nano[P66614][RhB][FL] was demonstrated to be facile at small scale. 
However, for commercial use, scalability studies should be performed. While 
photostability and thermostability were found to be favorable, practical storage and 
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